data_2ml7_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2ml7 _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 29.5 p . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.896 0.379 . . . . 24.140000000000001 110.883 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.52 ' HB3' ' HB2' ' A' ' 6' ' ' ALA . 0.0 OUTLIER -65.58 143.75 57.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.205 -0.452 . . . . 54.32 110.903 179.924 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -94.47 21.75 6.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.201 -0.454 . . . . 65.409999999999997 110.908 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 92.65 151.66 28.0 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.75 -0.738 . . . . 74.219999999999999 112.489 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 50.89 27.73 14.46 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.701 -0.762 . . . . 63.509999999999998 112.538 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.52 ' HB2' ' HB3' ' A' ' 2' ' ' LYS . . . -108.44 149.36 28.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.803 0.335 . . . . 63.520000000000003 111.135 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -75.32 135.34 40.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 72.209999999999994 110.914 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -131.2 -69.14 0.64 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.245 -0.434 . . . . 71.209999999999994 110.903 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 73.42 -85.79 0.61 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.712 -0.756 . . . . 61.049999999999997 112.52 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -51.32 -34.82 35.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.802 0.334 . . . . 71.340000000000003 110.851 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -111.73 82.4 3.89 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.541 0.686 . . . . 62.310000000000002 110.83 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.87 -7.44 21.08 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.686 2.257 . . . . 65.200000000000003 112.358 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 37.2 m-70 -130.82 21.4 5.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.456 . . . . 71.530000000000001 110.867 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -101.31 85.94 0.59 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.75 -0.738 . . . . 74.549999999999997 112.513 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 61.6 m -143.48 145.76 32.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.843 0.354 . . . . 63.439999999999998 110.964 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -56.84 -55.58 32.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 73.299999999999997 110.843 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.32 -159.74 35.72 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.761 -0.733 . . . . 52.119999999999997 112.458 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -88.46 50.97 2.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.865 0.364 . . . . 74.430000000000007 110.938 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.419 ' HA ' ' HA3' ' A' ' 28' ' ' GLY . 14.3 m -113.76 151.3 32.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.233 -0.44 . . . . 71.219999999999999 110.815 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -129.91 162.44 22.97 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.725 -0.75 . . . . 73.230000000000004 112.484 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 14.6 m -89.18 61.41 5.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.871 0.367 . . . . 65.349999999999994 110.868 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.494 HD12 ' CD2' ' A' ' 27' ' ' TYR . 2.5 pt? -49.77 -29.99 8.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 65.109999999999999 110.856 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.433 ' O ' HG23 ' A' ' 23' ' ' VAL . 7.0 p -142.83 20.45 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 64.239999999999995 111.111 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 108.34 -13.34 36.55 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.668 -0.777 . . . . 34.439999999999998 112.562 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -115.95 135.66 53.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.827 0.346 . . . . 75.329999999999998 110.911 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 17.5 m -64.35 109.6 1.97 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.189 -0.46 . . . . 65.239999999999995 110.874 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.494 ' CD2' HD12 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -128.76 117.59 21.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.191 -0.459 . . . . 71.319999999999993 110.979 -179.922 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.419 ' HA3' ' HA ' ' A' ' 19' ' ' CYS . . . -153.33 -132.84 1.78 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.711 -0.757 . . . . 45.32 112.504 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.9 m -150.33 29.72 0.7 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.787 0.327 . . . . 62.439999999999998 111.153 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -141.09 -55.28 0.04 OUTLIER Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.653 -0.784 . . . . 70.510000000000005 112.441 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 27.6 p . . . . . 0 C--N 1.328 -0.337 0 CA-C-O 120.765 0.316 . . . . 51.32 110.862 -179.834 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 29.0 p . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.947 0.403 . . . . 52.229999999999997 110.898 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.55 125.89 27.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.15 -0.477 . . . . 73.129999999999995 110.828 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.73 -12.42 61.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 75.120000000000005 110.931 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 131.69 152.13 7.09 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.712 -0.756 . . . . 72.109999999999999 112.455 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 51.6 26.18 15.65 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.741 -0.743 . . . . 75.200000000000003 112.473 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -103.44 151.54 22.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.753 0.311 . . . . 71.219999999999999 111.104 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -77.85 136.22 38.04 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.257 -0.429 . . . . 74.219999999999999 110.868 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -131.19 -70.45 0.6 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.221 -0.445 . . . . 53.43 110.878 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 75.08 -85.17 0.8 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.65 -0.786 . . . . 61.439999999999998 112.505 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -51.88 -35.97 46.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.855 0.36 . . . . 74.310000000000002 110.856 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -110.58 82.14 2.73 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.621 0.724 . . . . 64.510000000000005 110.897 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -8.56 23.93 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.729 2.286 . . . . 74.409999999999997 112.377 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 6.1 m170 -128.24 19.3 6.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.246 -0.434 . . . . 71.219999999999999 110.87 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -100.47 88.36 0.76 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.818 -0.706 . . . . 65.510000000000005 112.519 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 65.6 m -144.76 143.83 30.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.866 0.365 . . . . 70.030000000000001 110.867 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -54.61 -56.76 15.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 63.119999999999997 110.927 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.32 -158.6 34.44 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.731 -0.747 . . . . 62.109999999999999 112.567 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -88.69 50.77 2.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.85 0.357 . . . . 73.140000000000001 110.878 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.406 ' HA ' ' HA3' ' A' ' 28' ' ' GLY . 14.2 m -113.5 153.75 28.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.166 -0.47 . . . . 62.130000000000003 110.831 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -132.25 162.51 23.98 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.7 -0.762 . . . . 71.510000000000005 112.471 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 14.2 m -88.97 61.3 5.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.888 0.375 . . . . 74.409999999999997 110.896 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.503 HD12 ' CD2' ' A' ' 27' ' ' TYR . 2.6 pt? -49.67 -30.14 8.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.231 -0.441 . . . . 53.210000000000001 110.919 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.426 ' O ' HG22 ' A' ' 23' ' ' VAL . 6.9 p -143.92 22.8 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.114 -0.494 . . . . 72.019999999999996 111.109 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 107.11 -15.05 40.08 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.732 -0.747 . . . . 51.100000000000001 112.481 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -114.98 135.75 53.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.885 0.374 . . . . 73.319999999999993 110.851 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 15.7 m -65.14 111.0 2.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 71.140000000000001 110.902 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.503 ' CD2' HD12 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -129.28 117.88 21.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.115 -0.493 . . . . 74.140000000000001 110.896 -179.881 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.406 ' HA3' ' HA ' ' A' ' 19' ' ' CYS . . . -153.45 -132.6 1.74 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.771 -0.728 . . . . 73.010000000000005 112.516 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.9 m -150.38 29.55 0.7 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.862 0.363 . . . . 73.420000000000002 111.116 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -141.01 -55.03 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.791 -0.719 . . . . 44.200000000000003 112.547 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 26.9 p . . . . . 0 C--N 1.328 -0.358 0 CA-C-O 120.775 0.322 . . . . 71.140000000000001 110.885 -179.916 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 5.1 p . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.914 0.388 . . . . 75.310000000000002 110.905 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.8 -169.03 0.11 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 74.409999999999997 110.901 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -128.6 20.83 6.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.45 . . . . 72.019999999999996 110.851 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 88.82 152.5 25.56 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.755 -0.736 . . . . 60.030000000000001 112.552 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 51.78 25.49 15.51 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.738 -0.744 . . . . 61.0 112.464 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -107.85 157.23 18.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.778 0.323 . . . . 63.219999999999999 111.119 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -76.71 133.63 39.45 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.197 -0.456 . . . . 71.329999999999998 110.849 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -130.19 -74.14 0.55 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.24 -0.436 . . . . 64.109999999999999 110.875 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.5 -78.27 1.95 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.748 -0.739 . . . . 54.520000000000003 112.427 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -56.65 -34.75 67.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.874 0.368 . . . . 72.319999999999993 110.917 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -112.4 77.22 2.19 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.591 0.71 . . . . 71.219999999999999 110.865 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 -6.4 18.54 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.668 2.246 . . . . 63.32 112.327 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 9.7 p80 -138.06 24.17 2.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.445 . . . . 61.43 110.835 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -121.96 114.44 2.52 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.772 -0.728 . . . . 61.109999999999999 112.493 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -160.92 178.47 9.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.853 0.359 . . . . 70.0 110.872 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -72.4 -22.99 61.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.191 -0.459 . . . . 50.030000000000001 110.808 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -130.52 -162.17 10.61 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.748 -0.739 . . . . 71.239999999999995 112.436 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -88.67 48.51 1.64 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.892 0.377 . . . . 64.329999999999998 110.92 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.408 ' HA ' ' HA3' ' A' ' 28' ' ' GLY . 7.9 m -113.09 127.43 56.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.169 -0.469 . . . . 65.209999999999994 110.879 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -104.57 157.17 16.93 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.8 -0.714 . . . . 70.200000000000003 112.499 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 13.2 m -87.3 65.17 8.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.825 0.345 . . . . 63.009999999999998 110.843 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -50.2 -30.41 11.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.117 -0.492 . . . . 64.420000000000002 110.848 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.43 ' O ' HG23 ' A' ' 23' ' ' VAL . 7.5 p -145.0 24.88 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.248 -0.433 . . . . 51.119999999999997 111.142 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 109.17 -23.84 22.21 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.727 -0.749 . . . . 53.200000000000003 112.479 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -106.15 130.5 54.03 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.918 0.389 . . . . 73.010000000000005 110.835 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 1.2 m -65.37 106.93 1.49 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 52.420000000000002 110.904 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.409 ' O ' ' CG ' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -121.93 118.93 30.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.156 -0.474 . . . . 73.430000000000007 110.954 -179.908 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.408 ' HA3' ' HA ' ' A' ' 19' ' ' CYS . . . -153.5 -133.21 1.81 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.667 -0.778 . . . . 70.319999999999993 112.47 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.2 m -150.28 31.24 0.68 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.864 0.364 . . . . 74.530000000000001 111.126 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.418 ' O ' ' OXT' ' A' ' 31' ' ' CYS . . . -139.62 -58.47 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.711 -0.757 . . . . 75.510000000000005 112.464 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.418 ' OXT' ' O ' ' A' ' 30' ' ' GLY . 31.3 p . . . . . 0 C--N 1.328 -0.348 0 CA-C-O 120.79 0.329 . . . . 54.409999999999997 110.86 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 5.7 p . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.956 0.408 . . . . 63.329999999999998 110.887 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . 0.562 ' HB3' ' HB2' ' A' ' 6' ' ' ALA . 0.0 OUTLIER -72.07 128.45 35.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 60.009999999999998 110.896 179.961 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -94.41 25.82 3.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 74.430000000000007 110.869 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 100.15 149.45 23.77 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.723 -0.751 . . . . 14.210000000000001 112.476 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 49.76 34.59 21.95 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.796 -0.716 . . . . 61.25 112.433 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.562 ' HB2' ' HB3' ' A' ' 2' ' ' LYS . . . -108.97 143.55 38.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.83 0.347 . . . . 70.129999999999995 111.073 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -72.59 132.32 43.61 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.181 -0.463 . . . . 75.219999999999999 110.999 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -131.35 -69.95 0.61 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.441 . . . . 60.109999999999999 110.825 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 75.14 -85.11 0.81 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.776 -0.726 . . . . 63.210000000000001 112.443 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -52.52 -36.86 56.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.901 0.382 . . . . 65.430000000000007 110.922 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -109.98 85.64 4.32 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.614 0.721 . . . . 73.140000000000001 110.88 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.83 -5.86 17.26 Favored 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.639 2.226 . . . . 64.310000000000002 112.279 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 26.0 m-70 -136.75 23.17 3.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.302 -0.408 . . . . 75.109999999999999 110.85 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -102.67 86.33 0.55 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.778 -0.725 . . . . 74.329999999999998 112.531 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 38.2 m -141.38 162.67 34.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.848 0.356 . . . . 53.229999999999997 110.934 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -60.15 -45.72 92.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.168 -0.469 . . . . 75.200000000000003 110.873 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -111.11 -146.24 10.52 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.748 -0.739 . . . . 72.040000000000006 112.487 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -88.9 41.08 1.01 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.907 0.384 . . . . 65.409999999999997 110.905 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.407 ' HA ' ' HA3' ' A' ' 28' ' ' GLY . 67.8 m -89.48 142.22 27.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 75.140000000000001 110.855 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -126.01 148.85 17.19 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.74 -0.743 . . . . 63.399999999999999 112.498 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 14.1 m -88.73 63.74 7.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.846 0.355 . . . . 70.450000000000003 110.862 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -49.64 -27.98 5.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.187 -0.461 . . . . 74.120000000000005 110.912 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.424 ' O ' HG23 ' A' ' 23' ' ' VAL . 7.1 p -145.31 18.88 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 72.040000000000006 111.162 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 109.65 -10.26 32.62 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.733 -0.746 . . . . 74.510000000000005 112.508 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -115.09 129.45 56.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.906 0.384 . . . . 74.319999999999993 110.879 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 5.8 m -59.18 127.91 34.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.151 -0.477 . . . . 74.510000000000005 110.838 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -150.05 116.87 5.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 75.019999999999996 110.989 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.407 ' HA3' ' HA ' ' A' ' 19' ' ' CYS . . . -154.28 -133.98 1.87 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.754 -0.736 . . . . 53.240000000000002 112.482 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.407 HG22 ' O ' ' A' ' 29' ' ' THR . 3.8 m -150.9 32.79 0.6 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.857 0.36 . . . . 65.310000000000002 111.124 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -150.4 15.79 0.98 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.768 -0.729 . . . . 62.200000000000003 112.502 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 5.6 m . . . . . 0 C--N 1.329 -0.311 0 CA-C-O 120.801 0.334 . . . . 73.319999999999993 110.907 -179.965 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 2.5 p . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.904 0.383 . . . . 62.240000000000002 110.906 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -72.05 -168.66 0.41 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 71.319999999999993 110.886 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -126.78 17.03 7.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 44.030000000000001 110.852 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 87.56 157.08 30.94 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.806 -0.711 . . . . 73.340000000000003 112.488 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 51.83 27.33 20.26 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.718 -0.753 . . . . 74.430000000000007 112.525 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -115.96 155.37 28.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.735 0.302 . . . . 74.409999999999997 111.14 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -74.18 131.38 41.2 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.215 -0.448 . . . . 72.430000000000007 110.891 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -129.5 -76.23 0.55 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.234 -0.439 . . . . 43.030000000000001 110.902 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 84.15 -60.58 4.82 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.713 -0.756 . . . . 64.329999999999998 112.515 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 56.1 p90 -63.21 -38.95 93.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.882 0.373 . . . . 71.349999999999994 110.872 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -116.03 76.14 6.2 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.582 0.706 . . . . 72.129999999999995 110.865 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.75 -5.4 16.12 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.65 2.233 . . . . 72.310000000000002 112.323 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -144.33 24.14 1.61 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 60.149999999999999 110.838 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -105.18 -91.3 2.22 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.697 -0.763 . . . . 30.550000000000001 112.474 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 49.93 -170.45 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.92 0.39 . . . . 54.530000000000001 110.853 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -81.52 -59.16 2.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.475 . . . . 70.519999999999996 110.897 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.73 -156.55 32.13 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.773 -0.727 . . . . 73.329999999999998 112.522 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 11.2 p-10 -88.96 47.8 1.55 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.834 0.349 . . . . 74.519999999999996 110.878 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.411 ' HA ' ' HA3' ' A' ' 28' ' ' GLY . 9.5 m -112.64 138.74 48.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.182 -0.463 . . . . 71.450000000000003 110.87 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -118.8 156.35 15.7 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.728 -0.749 . . . . 71.109999999999999 112.518 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 5.7 m -87.98 65.98 8.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.892 0.377 . . . . 53.119999999999997 110.913 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -49.67 -31.41 10.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.124 -0.489 . . . . 71.430000000000007 110.909 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.461 ' O ' HG23 ' A' ' 23' ' ' VAL . 9.8 p -144.89 28.85 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 64.219999999999999 111.076 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 110.2 -38.59 3.24 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.83 -0.7 . . . . 54.25 112.445 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -96.1 131.27 42.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.862 0.363 . . . . 75.0 110.886 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 1.7 m -64.46 126.15 26.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.248 -0.433 . . . . 74.319999999999993 110.87 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.426 ' O ' ' CG ' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -137.42 118.53 14.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 71.549999999999997 110.943 -179.931 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.411 ' HA3' ' HA ' ' A' ' 19' ' ' CYS . . . -153.98 -134.33 1.94 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.758 -0.734 . . . . 63.32 112.51 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.1 m -150.14 30.67 0.7 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.782 0.325 . . . . 64.120000000000005 111.179 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -140.38 -55.4 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.782 -0.723 . . . . 64.310000000000002 112.526 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 27.1 p . . . . . 0 C--N 1.328 -0.337 0 CA-C-O 120.817 0.342 . . . . 64.25 110.829 -179.866 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 5.2 p . . . . . 0 C--O 1.232 0.18 0 CA-C-O 120.921 0.391 . . . . 72.549999999999997 110.835 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.77 142.24 46.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 73.230000000000004 110.82 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -98.73 20.43 13.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.173 -0.467 . . . . 72.25 110.876 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 101.82 150.03 22.99 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.783 -0.722 . . . . 73.120000000000005 112.47 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 49.93 29.45 14.0 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.745 -0.741 . . . . 75.349999999999994 112.459 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -107.99 129.69 55.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.747 0.308 . . . . 74.129999999999995 111.116 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -59.58 132.62 54.55 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.261 -0.427 . . . . 74.329999999999998 110.925 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -128.48 -73.04 0.59 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 75.420000000000002 110.869 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 78.33 -83.16 1.22 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.744 -0.741 . . . . 74.209999999999994 112.454 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -53.68 -34.56 59.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.845 0.355 . . . . 71.439999999999998 110.897 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -113.16 85.67 8.54 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.654 0.74 . . . . 64.049999999999997 110.85 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.82 -8.08 22.7 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.731 2.287 . . . . 65.120000000000005 112.33 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 25.6 p80 -133.02 21.51 4.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 72.209999999999994 110.875 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -99.35 86.33 0.7 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.743 -0.741 . . . . 74.450000000000003 112.555 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 52.6 m -141.9 154.8 45.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.841 0.353 . . . . 73.430000000000007 110.932 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -72.99 -22.39 60.69 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.171 -0.468 . . . . 74.540000000000006 110.875 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -121.27 -159.51 10.74 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.806 -0.711 . . . . 64.230000000000004 112.496 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -89.3 48.58 1.63 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.873 0.368 . . . . 74.150000000000006 110.861 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.457 ' HA ' ' HA3' ' A' ' 28' ' ' GLY . 6.5 m -110.54 149.83 29.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 62.25 110.858 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -127.71 156.9 20.79 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.693 -0.765 . . . . 52.25 112.49 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 22.4 m -88.88 57.94 4.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.875 0.369 . . . . 74.329999999999998 110.893 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.405 ' HG ' HG21 ' A' ' 23' ' ' VAL . 2.5 pt? -48.09 -33.97 8.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.194 -0.457 . . . . 74.430000000000007 110.922 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.405 HG21 ' HG ' ' A' ' 22' ' ' LEU . 1.8 m -133.3 9.63 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.471 . . . . 75.340000000000003 111.053 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 116.01 -7.52 19.19 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.679 -0.772 . . . . 53.119999999999997 112.449 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -119.6 136.08 54.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.919 0.39 . . . . 74.329999999999998 110.877 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 11.9 m -63.26 102.37 0.39 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.137 -0.483 . . . . 73.430000000000007 110.905 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.452 ' O ' ' CG ' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -118.75 115.07 23.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 74.299999999999997 110.892 -179.801 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.457 ' HA3' ' HA ' ' A' ' 19' ' ' CYS . . . -154.22 -140.02 2.95 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.767 -0.73 . . . . 61.240000000000002 112.522 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 4.0 m -150.82 36.89 0.63 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.796 0.331 . . . . 54.32 111.099 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -146.66 -38.06 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.696 -0.764 . . . . 62.020000000000003 112.436 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 33.3 m . . . . . 0 C--N 1.328 -0.335 0 CA-C-O 120.786 0.327 . . . . 74.530000000000001 110.856 -179.863 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 2.6 p . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.937 0.399 . . . . 44.43 110.845 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.48 -167.96 0.05 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.158 -0.474 . . . . 74.129999999999995 110.896 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -129.01 18.84 6.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.231 -0.441 . . . . 54.049999999999997 110.869 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 86.1 157.0 28.77 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.726 -0.75 . . . . 73.400000000000006 112.52 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 51.96 26.73 19.64 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.81 -0.709 . . . . 73.099999999999994 112.503 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -114.79 155.87 25.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.8 0.334 . . . . 75.219999999999999 111.111 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -74.48 131.08 40.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.155 -0.475 . . . . 64.019999999999996 110.905 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -128.23 -75.95 0.56 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.258 -0.428 . . . . 71.409999999999997 110.967 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 85.08 -64.71 4.18 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.705 -0.76 . . . . 33.229999999999997 112.492 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 55.7 p90 -61.65 -39.27 90.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.932 0.396 . . . . 75.340000000000003 110.873 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -114.43 76.52 3.85 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.595 0.712 . . . . 42.420000000000002 110.839 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.74 -5.37 16.04 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.7 2.267 . . . . 73.030000000000001 112.372 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 11.3 p80 -144.9 23.26 1.56 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 74.150000000000006 110.9 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -101.65 -92.34 2.17 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.72 -0.752 . . . . 44.409999999999997 112.451 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 50.29 -171.2 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.878 0.371 . . . . 65.519999999999996 110.881 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -78.27 -62.26 1.74 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 63.340000000000003 110.858 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.66 -153.16 27.66 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.744 -0.741 . . . . 55.299999999999997 112.51 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -89.03 46.36 1.38 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.933 0.396 . . . . 75.319999999999993 110.875 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.412 ' HA ' ' HA3' ' A' ' 28' ' ' GLY . 34.0 m -107.38 134.95 49.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.125 -0.489 . . . . 72.340000000000003 110.835 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -117.57 154.26 16.77 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.699 -0.762 . . . . 71.209999999999994 112.482 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 5.4 m -88.13 67.4 8.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.89 0.376 . . . . 71.120000000000005 110.939 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -50.54 -27.99 7.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.469 . . . . 60.399999999999999 110.918 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.456 ' O ' HG22 ' A' ' 23' ' ' VAL . 9.5 p -148.01 28.28 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 73.549999999999997 111.151 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 109.9 -36.34 4.35 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.767 -0.73 . . . . 62.020000000000003 112.46 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -97.52 129.18 44.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.951 0.405 . . . . 61.340000000000003 110.825 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 2.7 m -62.65 130.32 44.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.47 . . . . 70.340000000000003 110.867 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.44 ' O ' ' CG ' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -142.84 117.88 10.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.129 -0.487 . . . . 70.400000000000006 110.975 -179.882 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.412 ' HA3' ' HA ' ' A' ' 19' ' ' CYS . . . -153.9 -132.26 1.66 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.729 -0.748 . . . . 33.030000000000001 112.503 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.0 m -150.36 29.27 0.71 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.84 0.352 . . . . 75.040000000000006 111.153 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.548 ' O ' ' OXT' ' A' ' 31' ' ' CYS . . . -138.11 -56.93 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.743 -0.741 . . . . 61.009999999999998 112.497 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.548 ' OXT' ' O ' ' A' ' 30' ' ' GLY . 29.9 p . . . . . 0 C--N 1.329 -0.291 0 CA-C-O 120.785 0.326 . . . . 62.140000000000001 110.846 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 2.6 p . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.829 0.347 . . . . 72.409999999999997 110.892 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.18 -168.8 0.68 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.192 -0.458 . . . . 73.010000000000005 110.878 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.466 ' O ' ' OXT' ' A' ' 31' ' ' CYS . 0.5 OUTLIER -130.64 18.73 5.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.45 . . . . 71.0 110.855 -179.887 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 95.44 155.92 31.49 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.667 -0.777 . . . . 42.530000000000001 112.478 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 51.64 27.49 19.18 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.825 -0.703 . . . . 51.329999999999998 112.423 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -113.29 149.61 33.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.792 0.33 . . . . 52.210000000000001 111.097 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -70.59 131.38 43.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.174 -0.466 . . . . 74.219999999999999 110.949 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -129.19 -76.11 0.55 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.228 -0.442 . . . . 75.209999999999994 110.85 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 85.98 -69.77 3.13 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.761 -0.733 . . . . 51.399999999999999 112.432 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -59.63 -39.43 84.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.795 0.331 . . . . 71.310000000000002 110.867 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -112.73 76.89 2.27 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.61 0.719 . . . . 74.319999999999993 110.83 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.68 -5.55 16.42 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.668 2.246 . . . . 70.319999999999993 112.36 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 11.6 p80 -144.45 23.57 1.62 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.259 -0.428 . . . . 61.420000000000002 110.808 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -99.65 -92.86 2.07 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.721 -0.752 . . . . 74.439999999999998 112.496 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 49.99 -170.16 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.936 0.398 . . . . 71.439999999999998 110.824 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -83.93 -59.87 2.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 52.25 110.912 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.79 -155.36 30.74 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.779 -0.724 . . . . 65.349999999999994 112.447 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -89.4 43.41 1.14 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.9 0.381 . . . . 61.350000000000001 110.947 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 5.4 m -107.13 121.76 45.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 55.210000000000001 110.879 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -103.55 155.81 17.84 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.742 -0.742 . . . . 62.43 112.458 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 5.0 m -88.32 71.13 9.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.857 0.36 . . . . 74.310000000000002 110.886 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.5 pp -47.49 -32.94 5.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.212 -0.449 . . . . 62.43 110.919 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.463 ' O ' HG23 ' A' ' 23' ' ' VAL . 9.9 p -147.29 30.83 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.2 -0.455 . . . . 71.230000000000004 111.163 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 109.66 -31.07 7.85 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.691 -0.766 . . . . 73.010000000000005 112.516 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -101.05 124.23 46.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.965 0.412 . . . . 73.310000000000002 110.852 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 6.8 m -61.33 131.41 50.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.112 -0.495 . . . . 73.400000000000006 110.875 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.465 ' O ' ' CG ' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -142.44 117.03 9.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 73.150000000000006 110.864 -179.894 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -154.09 -133.21 1.77 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.688 -0.768 . . . . 52.399999999999999 112.469 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.3 m -151.17 30.87 0.61 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.853 0.359 . . . . 65.209999999999994 111.158 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -150.39 15.21 0.97 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.775 -0.726 . . . . 21.109999999999999 112.481 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.466 ' OXT' ' O ' ' A' ' 3' ' ' SER . 4.8 m . . . . . 0 C--N 1.328 -0.33 0 CA-C-O 120.775 0.321 . . . . 74.430000000000007 110.905 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 17.6 p . . . . . 0 C--O 1.232 0.179 0 CA-C-O 120.886 0.374 . . . . 73.409999999999997 110.933 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.46 166.66 18.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.282 -0.417 . . . . 71.049999999999997 110.879 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -118.5 19.61 13.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 71.230000000000004 110.827 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 96.9 149.46 25.57 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.751 -0.738 . . . . 70.109999999999999 112.431 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 50.67 26.82 11.1 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.728 -0.749 . . . . 70.209999999999994 112.525 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -106.29 130.09 54.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.764 0.316 . . . . 74.400000000000006 111.1 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -58.52 134.21 56.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 61.219999999999999 110.958 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -126.88 -81.11 0.61 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.265 -0.425 . . . . 73.239999999999995 110.888 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 76.16 -62.61 2.96 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.758 -0.734 . . . . 42.210000000000001 112.481 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -50.43 -34.13 23.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.876 0.369 . . . . 73.129999999999995 110.903 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -146.08 115.87 4.73 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.628 0.728 . . . . 73.099999999999994 110.865 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 -8.01 22.51 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.665 2.243 . . . . 70.010000000000005 112.398 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -128.17 21.28 6.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.21 -0.45 . . . . 72.109999999999999 110.821 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -88.32 65.67 3.36 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.705 -0.759 . . . . 53.210000000000001 112.48 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 12.9 m -138.76 156.9 46.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.82 0.343 . . . . 75.129999999999995 110.94 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -53.5 -61.89 2.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 44.409999999999997 110.883 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.51 -152.26 26.06 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.755 -0.736 . . . . 74.439999999999998 112.517 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -88.79 46.23 1.37 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.854 0.359 . . . . 62.219999999999999 110.874 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.407 ' HA ' ' HA3' ' A' ' 28' ' ' GLY . 62.5 m -91.2 129.69 37.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.229 -0.441 . . . . 74.329999999999998 110.88 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -112.54 150.29 18.31 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.749 -0.738 . . . . 52.539999999999999 112.457 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 38.2 m -89.21 65.2 7.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.903 0.383 . . . . 54.210000000000001 110.87 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -44.77 -36.21 3.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.475 . . . . 74.420000000000002 110.918 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 25.8 t -134.91 8.23 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.465 . . . . 70.510000000000005 111.183 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 117.62 5.19 14.42 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.811 -0.709 . . . . 51.539999999999999 112.509 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -128.39 130.5 47.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.835 0.35 . . . . 73.409999999999997 110.903 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 56.1 m -51.57 124.46 12.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.156 -0.475 . . . . 64.510000000000005 110.84 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -150.52 111.17 4.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 74.329999999999998 110.928 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.407 ' HA3' ' HA ' ' A' ' 19' ' ' CYS . . . -153.78 -127.12 1.15 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.747 -0.739 . . . . 62.43 112.488 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.0 m -150.36 31.08 0.67 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.829 0.347 . . . . 75.519999999999996 111.16 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -138.48 -55.07 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.676 -0.773 . . . . 73.329999999999998 112.491 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.665 ' OXT' ' SG ' ' A' ' 31' ' ' CYS . 14.0 p . . . . . 0 C--N 1.33 -0.246 0 CA-C-O 120.806 0.336 . . . . 70.209999999999994 110.86 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 1.8 p . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.934 0.397 . . . . 64.109999999999999 110.869 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.9 mmpt? -76.15 -168.2 0.89 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.137 -0.483 . . . . 72.010000000000005 110.894 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.2 m -121.67 13.19 10.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.235 -0.439 . . . . 75.329999999999998 110.875 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 92.29 154.33 30.83 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.706 -0.759 . . . . 74.129999999999995 112.495 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 49.84 46.52 40.02 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.76 -0.733 . . . . 70.420000000000002 112.448 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -135.28 148.22 49.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.776 0.322 . . . . 43.039999999999999 111.116 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -64.12 128.79 37.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.16 -0.473 . . . . 73.400000000000006 110.945 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.7 p -117.48 -54.24 2.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.445 . . . . 63.340000000000003 110.876 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 70.57 -81.73 0.39 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.697 -0.763 . . . . 71.549999999999997 112.525 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -60.6 -37.18 80.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.873 0.368 . . . . 73.030000000000001 110.853 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -112.53 75.47 1.8 Allowed Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.608 0.718 . . . . 73.010000000000005 110.885 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.8 -5.84 17.2 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.678 2.252 . . . . 72.400000000000006 112.348 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -142.18 21.75 2.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.224 -0.444 . . . . 70.129999999999995 110.891 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -87.57 -95.07 0.94 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.723 -0.751 . . . . 30.010000000000002 112.453 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 51.07 -171.77 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.886 0.374 . . . . 72.329999999999998 110.84 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -89.14 -57.98 2.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.166 -0.47 . . . . 73.129999999999995 110.927 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.76 -157.08 32.79 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.765 -0.731 . . . . 75.439999999999998 112.478 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -88.44 49.32 1.77 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.841 0.353 . . . . 52.399999999999999 110.863 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.465 ' HA ' ' HA3' ' A' ' 28' ' ' GLY . 86.2 m -102.33 123.5 46.24 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.156 -0.475 . . . . 71.5 110.937 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -100.01 149.55 18.79 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.691 -0.766 . . . . 72.540000000000006 112.57 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 69.3 m -89.11 68.63 8.26 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.807 0.337 . . . . 73.200000000000003 110.862 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -49.29 -31.73 9.59 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.258 -0.428 . . . . 71.209999999999994 110.854 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.3 m -142.18 23.48 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.126 -0.488 . . . . 70.129999999999995 111.149 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 109.94 -29.45 9.3 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.753 -0.737 . . . . 75.230000000000004 112.506 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -98.77 130.88 45.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.959 0.409 . . . . 72.230000000000004 110.854 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 87.1 m -57.68 126.91 29.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 64.299999999999997 110.871 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.41 ' O ' ' CG ' ' A' ' 27' ' ' TYR . 0.1 OUTLIER -151.26 111.19 4.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.169 -0.469 . . . . 55.439999999999998 110.856 -179.909 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.465 ' HA3' ' HA ' ' A' ' 19' ' ' CYS . . . -154.81 -123.91 0.88 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.699 -0.762 . . . . 63.340000000000003 112.484 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.0 m -150.8 29.25 0.68 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.83 0.348 . . . . 75.299999999999997 111.11 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -129.54 -65.47 0.11 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.721 -0.752 . . . . 60.229999999999997 112.461 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 21.0 p . . . . . 0 C--N 1.328 -0.355 0 CA-C-O 120.796 0.331 . . . . 52.329999999999998 110.891 -179.872 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 29.5 p . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.896 0.379 . . . . 24.140000000000001 110.883 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.52 ' HB3' ' HB2' ' A' ' 6' ' ' ALA . 0.0 OUTLIER -65.58 143.75 57.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.205 -0.452 . . . . 54.32 110.903 179.924 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -94.47 21.75 6.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.201 -0.454 . . . . 65.409999999999997 110.908 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 92.65 151.66 28.0 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.75 -0.738 . . . . 74.219999999999999 112.489 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 50.89 27.73 14.46 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.701 -0.762 . . . . 63.509999999999998 112.538 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.52 ' HB2' ' HB3' ' A' ' 2' ' ' LYS . . . -108.44 149.36 28.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.803 0.335 . . . . 63.520000000000003 111.135 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -75.32 135.34 40.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 72.209999999999994 110.914 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -131.2 -69.14 0.64 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.245 -0.434 . . . . 71.209999999999994 110.903 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 73.42 -85.79 0.61 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.712 -0.756 . . . . 61.049999999999997 112.52 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -51.32 -34.82 35.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.802 0.334 . . . . 71.340000000000003 110.851 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -111.73 82.4 3.89 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.541 0.686 . . . . 62.310000000000002 110.83 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.87 -7.44 21.08 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.686 2.257 . . . . 65.200000000000003 112.358 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 37.2 m-70 -130.82 21.4 5.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.456 . . . . 71.530000000000001 110.867 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -101.31 85.94 0.59 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.75 -0.738 . . . . 74.549999999999997 112.513 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 61.6 m -143.48 145.76 32.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.843 0.354 . . . . 63.439999999999998 110.964 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -56.84 -55.58 32.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 73.299999999999997 110.843 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.32 -159.74 35.72 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.761 -0.733 . . . . 52.119999999999997 112.458 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -88.46 50.97 2.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.865 0.364 . . . . 74.430000000000007 110.938 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.419 ' HA ' ' HA3' ' A' ' 28' ' ' GLY . 14.3 m -113.76 151.3 32.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.233 -0.44 . . . . 71.219999999999999 110.815 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -129.91 162.44 22.97 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.725 -0.75 . . . . 73.230000000000004 112.484 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 14.6 m -89.18 61.41 5.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.871 0.367 . . . . 65.349999999999994 110.868 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.494 HD12 ' CD2' ' A' ' 27' ' ' TYR . 2.5 pt? -49.77 -29.99 8.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 65.109999999999999 110.856 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.433 ' O ' HG23 ' A' ' 23' ' ' VAL . 7.0 p -142.83 20.45 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 64.239999999999995 111.111 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 108.34 -13.34 36.55 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.668 -0.777 . . . . 34.439999999999998 112.562 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -115.95 135.66 53.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.827 0.346 . . . . 75.329999999999998 110.911 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 17.5 m -64.35 109.6 1.97 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.189 -0.46 . . . . 65.239999999999995 110.874 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.494 ' CD2' HD12 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -128.76 117.59 21.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.191 -0.459 . . . . 71.319999999999993 110.979 -179.922 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.419 ' HA3' ' HA ' ' A' ' 19' ' ' CYS . . . -153.33 -132.84 1.78 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.711 -0.757 . . . . 45.32 112.504 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.9 m -150.33 29.72 0.7 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.787 0.327 . . . . 62.439999999999998 111.153 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -141.09 -55.28 0.04 OUTLIER Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.653 -0.784 . . . . 70.510000000000005 112.441 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 27.6 p . . . . . 0 C--N 1.328 -0.337 0 CA-C-O 120.765 0.316 . . . . 51.32 110.862 -179.834 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 29.0 p . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.947 0.403 . . . . 52.229999999999997 110.898 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.55 125.89 27.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.15 -0.477 . . . . 73.129999999999995 110.828 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.73 -12.42 61.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 75.120000000000005 110.931 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 131.69 152.13 7.09 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.712 -0.756 . . . . 72.109999999999999 112.455 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 51.6 26.18 15.65 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.741 -0.743 . . . . 75.200000000000003 112.473 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -103.44 151.54 22.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.753 0.311 . . . . 71.219999999999999 111.104 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -77.85 136.22 38.04 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.257 -0.429 . . . . 74.219999999999999 110.868 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -131.19 -70.45 0.6 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.221 -0.445 . . . . 53.43 110.878 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 75.08 -85.17 0.8 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.65 -0.786 . . . . 61.439999999999998 112.505 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -51.88 -35.97 46.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.855 0.36 . . . . 74.310000000000002 110.856 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -110.58 82.14 2.73 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.621 0.724 . . . . 64.510000000000005 110.897 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -8.56 23.93 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.729 2.286 . . . . 74.409999999999997 112.377 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 6.1 m170 -128.24 19.3 6.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.246 -0.434 . . . . 71.219999999999999 110.87 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -100.47 88.36 0.76 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.818 -0.706 . . . . 65.510000000000005 112.519 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 65.6 m -144.76 143.83 30.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.866 0.365 . . . . 70.030000000000001 110.867 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -54.61 -56.76 15.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 63.119999999999997 110.927 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.32 -158.6 34.44 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.731 -0.747 . . . . 62.109999999999999 112.567 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -88.69 50.77 2.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.85 0.357 . . . . 73.140000000000001 110.878 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.406 ' HA ' ' HA3' ' A' ' 28' ' ' GLY . 14.2 m -113.5 153.75 28.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.166 -0.47 . . . . 62.130000000000003 110.831 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -132.25 162.51 23.98 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.7 -0.762 . . . . 71.510000000000005 112.471 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 14.2 m -88.97 61.3 5.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.888 0.375 . . . . 74.409999999999997 110.896 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.503 HD12 ' CD2' ' A' ' 27' ' ' TYR . 2.6 pt? -49.67 -30.14 8.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.231 -0.441 . . . . 53.210000000000001 110.919 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.426 ' O ' HG22 ' A' ' 23' ' ' VAL . 6.9 p -143.92 22.8 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.114 -0.494 . . . . 72.019999999999996 111.109 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 107.11 -15.05 40.08 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.732 -0.747 . . . . 51.100000000000001 112.481 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -114.98 135.75 53.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.885 0.374 . . . . 73.319999999999993 110.851 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 15.7 m -65.14 111.0 2.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 71.140000000000001 110.902 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.503 ' CD2' HD12 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -129.28 117.88 21.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.115 -0.493 . . . . 74.140000000000001 110.896 -179.881 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.406 ' HA3' ' HA ' ' A' ' 19' ' ' CYS . . . -153.45 -132.6 1.74 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.771 -0.728 . . . . 73.010000000000005 112.516 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.9 m -150.38 29.55 0.7 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.862 0.363 . . . . 73.420000000000002 111.116 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -141.01 -55.03 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.791 -0.719 . . . . 44.200000000000003 112.547 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 26.9 p . . . . . 0 C--N 1.328 -0.358 0 CA-C-O 120.775 0.322 . . . . 71.140000000000001 110.885 -179.916 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 5.1 p . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.914 0.388 . . . . 75.310000000000002 110.905 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.8 -169.03 0.11 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 74.409999999999997 110.901 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -128.6 20.83 6.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.45 . . . . 72.019999999999996 110.851 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 88.82 152.5 25.56 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.755 -0.736 . . . . 60.030000000000001 112.552 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 51.78 25.49 15.51 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.738 -0.744 . . . . 61.0 112.464 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -107.85 157.23 18.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.778 0.323 . . . . 63.219999999999999 111.119 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -76.71 133.63 39.45 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.197 -0.456 . . . . 71.329999999999998 110.849 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -130.19 -74.14 0.55 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.24 -0.436 . . . . 64.109999999999999 110.875 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.5 -78.27 1.95 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.748 -0.739 . . . . 54.520000000000003 112.427 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -56.65 -34.75 67.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.874 0.368 . . . . 72.319999999999993 110.917 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -112.4 77.22 2.19 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.591 0.71 . . . . 71.219999999999999 110.865 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 -6.4 18.54 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.668 2.246 . . . . 63.32 112.327 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 9.7 p80 -138.06 24.17 2.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.445 . . . . 61.43 110.835 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -121.96 114.44 2.52 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.772 -0.728 . . . . 61.109999999999999 112.493 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -160.92 178.47 9.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.853 0.359 . . . . 70.0 110.872 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -72.4 -22.99 61.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.191 -0.459 . . . . 50.030000000000001 110.808 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -130.52 -162.17 10.61 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.748 -0.739 . . . . 71.239999999999995 112.436 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -88.67 48.51 1.64 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.892 0.377 . . . . 64.329999999999998 110.92 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.408 ' HA ' ' HA3' ' A' ' 28' ' ' GLY . 7.9 m -113.09 127.43 56.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.169 -0.469 . . . . 65.209999999999994 110.879 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -104.57 157.17 16.93 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.8 -0.714 . . . . 70.200000000000003 112.499 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 13.2 m -87.3 65.17 8.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.825 0.345 . . . . 63.009999999999998 110.843 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -50.2 -30.41 11.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.117 -0.492 . . . . 64.420000000000002 110.848 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.43 ' O ' HG23 ' A' ' 23' ' ' VAL . 7.5 p -145.0 24.88 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.248 -0.433 . . . . 51.119999999999997 111.142 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 109.17 -23.84 22.21 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.727 -0.749 . . . . 53.200000000000003 112.479 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -106.15 130.5 54.03 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.918 0.389 . . . . 73.010000000000005 110.835 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 1.2 m -65.37 106.93 1.49 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 52.420000000000002 110.904 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.409 ' O ' ' CG ' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -121.93 118.93 30.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.156 -0.474 . . . . 73.430000000000007 110.954 -179.908 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.408 ' HA3' ' HA ' ' A' ' 19' ' ' CYS . . . -153.5 -133.21 1.81 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.667 -0.778 . . . . 70.319999999999993 112.47 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.2 m -150.28 31.24 0.68 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.864 0.364 . . . . 74.530000000000001 111.126 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.418 ' O ' ' OXT' ' A' ' 31' ' ' CYS . . . -139.62 -58.47 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.711 -0.757 . . . . 75.510000000000005 112.464 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.418 ' OXT' ' O ' ' A' ' 30' ' ' GLY . 31.3 p . . . . . 0 C--N 1.328 -0.348 0 CA-C-O 120.79 0.329 . . . . 54.409999999999997 110.86 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 5.7 p . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.956 0.408 . . . . 63.329999999999998 110.887 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.562 ' HB3' ' HB2' ' A' ' 6' ' ' ALA . 0.0 OUTLIER -72.07 128.45 35.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 60.009999999999998 110.896 179.961 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -94.41 25.82 3.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 74.430000000000007 110.869 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 100.15 149.45 23.77 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.723 -0.751 . . . . 14.210000000000001 112.476 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 49.76 34.59 21.95 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.796 -0.716 . . . . 61.25 112.433 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.562 ' HB2' ' HB3' ' A' ' 2' ' ' LYS . . . -108.97 143.55 38.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.83 0.347 . . . . 70.129999999999995 111.073 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -72.59 132.32 43.61 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.181 -0.463 . . . . 75.219999999999999 110.999 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -131.35 -69.95 0.61 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.441 . . . . 60.109999999999999 110.825 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 75.14 -85.11 0.81 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.776 -0.726 . . . . 63.210000000000001 112.443 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -52.52 -36.86 56.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.901 0.382 . . . . 65.430000000000007 110.922 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -109.98 85.64 4.32 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.614 0.721 . . . . 73.140000000000001 110.88 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.83 -5.86 17.26 Favored 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.639 2.226 . . . . 64.310000000000002 112.279 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 26.0 m-70 -136.75 23.17 3.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.302 -0.408 . . . . 75.109999999999999 110.85 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -102.67 86.33 0.55 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.778 -0.725 . . . . 74.329999999999998 112.531 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 38.2 m -141.38 162.67 34.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.848 0.356 . . . . 53.229999999999997 110.934 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -60.15 -45.72 92.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.168 -0.469 . . . . 75.200000000000003 110.873 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -111.11 -146.24 10.52 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.748 -0.739 . . . . 72.040000000000006 112.487 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -88.9 41.08 1.01 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.907 0.384 . . . . 65.409999999999997 110.905 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.407 ' HA ' ' HA3' ' A' ' 28' ' ' GLY . 67.8 m -89.48 142.22 27.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 75.140000000000001 110.855 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -126.01 148.85 17.19 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.74 -0.743 . . . . 63.399999999999999 112.498 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 14.1 m -88.73 63.74 7.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.846 0.355 . . . . 70.450000000000003 110.862 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -49.64 -27.98 5.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.187 -0.461 . . . . 74.120000000000005 110.912 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.424 ' O ' HG23 ' A' ' 23' ' ' VAL . 7.1 p -145.31 18.88 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 72.040000000000006 111.162 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 109.65 -10.26 32.62 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.733 -0.746 . . . . 74.510000000000005 112.508 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -115.09 129.45 56.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.906 0.384 . . . . 74.319999999999993 110.879 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 5.8 m -59.18 127.91 34.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.151 -0.477 . . . . 74.510000000000005 110.838 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -150.05 116.87 5.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 75.019999999999996 110.989 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.407 ' HA3' ' HA ' ' A' ' 19' ' ' CYS . . . -154.28 -133.98 1.87 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.754 -0.736 . . . . 53.240000000000002 112.482 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.407 HG22 ' O ' ' A' ' 29' ' ' THR . 3.8 m -150.9 32.79 0.6 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.857 0.36 . . . . 65.310000000000002 111.124 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -150.4 15.79 0.98 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.768 -0.729 . . . . 62.200000000000003 112.502 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 5.6 m . . . . . 0 C--N 1.329 -0.311 0 CA-C-O 120.801 0.334 . . . . 73.319999999999993 110.907 -179.965 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 2.5 p . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.904 0.383 . . . . 62.240000000000002 110.906 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -72.05 -168.66 0.41 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 71.319999999999993 110.886 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -126.78 17.03 7.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 44.030000000000001 110.852 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 87.56 157.08 30.94 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.806 -0.711 . . . . 73.340000000000003 112.488 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 51.83 27.33 20.26 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.718 -0.753 . . . . 74.430000000000007 112.525 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -115.96 155.37 28.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.735 0.302 . . . . 74.409999999999997 111.14 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -74.18 131.38 41.2 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.215 -0.448 . . . . 72.430000000000007 110.891 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -129.5 -76.23 0.55 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.234 -0.439 . . . . 43.030000000000001 110.902 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 84.15 -60.58 4.82 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.713 -0.756 . . . . 64.329999999999998 112.515 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 56.1 p90 -63.21 -38.95 93.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.882 0.373 . . . . 71.349999999999994 110.872 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -116.03 76.14 6.2 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.582 0.706 . . . . 72.129999999999995 110.865 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.75 -5.4 16.12 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.65 2.233 . . . . 72.310000000000002 112.323 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -144.33 24.14 1.61 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 60.149999999999999 110.838 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -105.18 -91.3 2.22 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.697 -0.763 . . . . 30.550000000000001 112.474 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 49.93 -170.45 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.92 0.39 . . . . 54.530000000000001 110.853 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -81.52 -59.16 2.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.475 . . . . 70.519999999999996 110.897 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.73 -156.55 32.13 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.773 -0.727 . . . . 73.329999999999998 112.522 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 11.2 p-10 -88.96 47.8 1.55 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.834 0.349 . . . . 74.519999999999996 110.878 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.411 ' HA ' ' HA3' ' A' ' 28' ' ' GLY . 9.5 m -112.64 138.74 48.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.182 -0.463 . . . . 71.450000000000003 110.87 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -118.8 156.35 15.7 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.728 -0.749 . . . . 71.109999999999999 112.518 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 5.7 m -87.98 65.98 8.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.892 0.377 . . . . 53.119999999999997 110.913 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -49.67 -31.41 10.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.124 -0.489 . . . . 71.430000000000007 110.909 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.461 ' O ' HG23 ' A' ' 23' ' ' VAL . 9.8 p -144.89 28.85 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 64.219999999999999 111.076 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 110.2 -38.59 3.24 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.83 -0.7 . . . . 54.25 112.445 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -96.1 131.27 42.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.862 0.363 . . . . 75.0 110.886 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 1.7 m -64.46 126.15 26.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.248 -0.433 . . . . 74.319999999999993 110.87 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.426 ' O ' ' CG ' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -137.42 118.53 14.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 71.549999999999997 110.943 -179.931 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.411 ' HA3' ' HA ' ' A' ' 19' ' ' CYS . . . -153.98 -134.33 1.94 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.758 -0.734 . . . . 63.32 112.51 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.1 m -150.14 30.67 0.7 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.782 0.325 . . . . 64.120000000000005 111.179 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -140.38 -55.4 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.782 -0.723 . . . . 64.310000000000002 112.526 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 27.1 p . . . . . 0 C--N 1.328 -0.337 0 CA-C-O 120.817 0.342 . . . . 64.25 110.829 -179.866 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 5.2 p . . . . . 0 C--O 1.232 0.18 0 CA-C-O 120.921 0.391 . . . . 72.549999999999997 110.835 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.77 142.24 46.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 73.230000000000004 110.82 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -98.73 20.43 13.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.173 -0.467 . . . . 72.25 110.876 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 101.82 150.03 22.99 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.783 -0.722 . . . . 73.120000000000005 112.47 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 49.93 29.45 14.0 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.745 -0.741 . . . . 75.349999999999994 112.459 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -107.99 129.69 55.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.747 0.308 . . . . 74.129999999999995 111.116 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -59.58 132.62 54.55 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.261 -0.427 . . . . 74.329999999999998 110.925 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -128.48 -73.04 0.59 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 75.420000000000002 110.869 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 78.33 -83.16 1.22 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.744 -0.741 . . . . 74.209999999999994 112.454 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -53.68 -34.56 59.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.845 0.355 . . . . 71.439999999999998 110.897 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -113.16 85.67 8.54 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.654 0.74 . . . . 64.049999999999997 110.85 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.82 -8.08 22.7 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.731 2.287 . . . . 65.120000000000005 112.33 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 25.6 p80 -133.02 21.51 4.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 72.209999999999994 110.875 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -99.35 86.33 0.7 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.743 -0.741 . . . . 74.450000000000003 112.555 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 52.6 m -141.9 154.8 45.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.841 0.353 . . . . 73.430000000000007 110.932 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -72.99 -22.39 60.69 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.171 -0.468 . . . . 74.540000000000006 110.875 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -121.27 -159.51 10.74 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.806 -0.711 . . . . 64.230000000000004 112.496 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -89.3 48.58 1.63 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.873 0.368 . . . . 74.150000000000006 110.861 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.457 ' HA ' ' HA3' ' A' ' 28' ' ' GLY . 6.5 m -110.54 149.83 29.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 62.25 110.858 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -127.71 156.9 20.79 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.693 -0.765 . . . . 52.25 112.49 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 22.4 m -88.88 57.94 4.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.875 0.369 . . . . 74.329999999999998 110.893 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.405 ' HG ' HG21 ' A' ' 23' ' ' VAL . 2.5 pt? -48.09 -33.97 8.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.194 -0.457 . . . . 74.430000000000007 110.922 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.405 HG21 ' HG ' ' A' ' 22' ' ' LEU . 1.8 m -133.3 9.63 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.471 . . . . 75.340000000000003 111.053 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 116.01 -7.52 19.19 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.679 -0.772 . . . . 53.119999999999997 112.449 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -119.6 136.08 54.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.919 0.39 . . . . 74.329999999999998 110.877 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 11.9 m -63.26 102.37 0.39 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.137 -0.483 . . . . 73.430000000000007 110.905 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.452 ' O ' ' CG ' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -118.75 115.07 23.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 74.299999999999997 110.892 -179.801 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.457 ' HA3' ' HA ' ' A' ' 19' ' ' CYS . . . -154.22 -140.02 2.95 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.767 -0.73 . . . . 61.240000000000002 112.522 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 4.0 m -150.82 36.89 0.63 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.796 0.331 . . . . 54.32 111.099 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -146.66 -38.06 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.696 -0.764 . . . . 62.020000000000003 112.436 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 33.3 m . . . . . 0 C--N 1.328 -0.335 0 CA-C-O 120.786 0.327 . . . . 74.530000000000001 110.856 -179.863 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 2.6 p . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.937 0.399 . . . . 44.43 110.845 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.48 -167.96 0.05 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.158 -0.474 . . . . 74.129999999999995 110.896 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -129.01 18.84 6.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.231 -0.441 . . . . 54.049999999999997 110.869 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 86.1 157.0 28.77 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.726 -0.75 . . . . 73.400000000000006 112.52 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 51.96 26.73 19.64 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.81 -0.709 . . . . 73.099999999999994 112.503 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -114.79 155.87 25.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.8 0.334 . . . . 75.219999999999999 111.111 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -74.48 131.08 40.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.155 -0.475 . . . . 64.019999999999996 110.905 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -128.23 -75.95 0.56 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.258 -0.428 . . . . 71.409999999999997 110.967 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 85.08 -64.71 4.18 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.705 -0.76 . . . . 33.229999999999997 112.492 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 55.7 p90 -61.65 -39.27 90.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.932 0.396 . . . . 75.340000000000003 110.873 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -114.43 76.52 3.85 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.595 0.712 . . . . 42.420000000000002 110.839 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.74 -5.37 16.04 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.7 2.267 . . . . 73.030000000000001 112.372 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 11.3 p80 -144.9 23.26 1.56 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 74.150000000000006 110.9 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -101.65 -92.34 2.17 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.72 -0.752 . . . . 44.409999999999997 112.451 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 50.29 -171.2 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.878 0.371 . . . . 65.519999999999996 110.881 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -78.27 -62.26 1.74 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 63.340000000000003 110.858 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.66 -153.16 27.66 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.744 -0.741 . . . . 55.299999999999997 112.51 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -89.03 46.36 1.38 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.933 0.396 . . . . 75.319999999999993 110.875 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.412 ' HA ' ' HA3' ' A' ' 28' ' ' GLY . 34.0 m -107.38 134.95 49.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.125 -0.489 . . . . 72.340000000000003 110.835 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -117.57 154.26 16.77 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.699 -0.762 . . . . 71.209999999999994 112.482 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 5.4 m -88.13 67.4 8.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.89 0.376 . . . . 71.120000000000005 110.939 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -50.54 -27.99 7.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.469 . . . . 60.399999999999999 110.918 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.456 ' O ' HG22 ' A' ' 23' ' ' VAL . 9.5 p -148.01 28.28 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 73.549999999999997 111.151 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 109.9 -36.34 4.35 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.767 -0.73 . . . . 62.020000000000003 112.46 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -97.52 129.18 44.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.951 0.405 . . . . 61.340000000000003 110.825 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 2.7 m -62.65 130.32 44.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.47 . . . . 70.340000000000003 110.867 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.44 ' O ' ' CG ' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -142.84 117.88 10.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.129 -0.487 . . . . 70.400000000000006 110.975 -179.882 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.412 ' HA3' ' HA ' ' A' ' 19' ' ' CYS . . . -153.9 -132.26 1.66 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.729 -0.748 . . . . 33.030000000000001 112.503 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.0 m -150.36 29.27 0.71 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.84 0.352 . . . . 75.040000000000006 111.153 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.548 ' O ' ' OXT' ' A' ' 31' ' ' CYS . . . -138.11 -56.93 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.743 -0.741 . . . . 61.009999999999998 112.497 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.548 ' OXT' ' O ' ' A' ' 30' ' ' GLY . 29.9 p . . . . . 0 C--N 1.329 -0.291 0 CA-C-O 120.785 0.326 . . . . 62.140000000000001 110.846 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 2.6 p . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.829 0.347 . . . . 72.409999999999997 110.892 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.18 -168.8 0.68 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.192 -0.458 . . . . 73.010000000000005 110.878 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.466 ' O ' ' OXT' ' A' ' 31' ' ' CYS . 0.5 OUTLIER -130.64 18.73 5.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.45 . . . . 71.0 110.855 -179.887 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 95.44 155.92 31.49 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.667 -0.777 . . . . 42.530000000000001 112.478 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 51.64 27.49 19.18 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.825 -0.703 . . . . 51.329999999999998 112.423 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -113.29 149.61 33.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.792 0.33 . . . . 52.210000000000001 111.097 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -70.59 131.38 43.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.174 -0.466 . . . . 74.219999999999999 110.949 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -129.19 -76.11 0.55 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.228 -0.442 . . . . 75.209999999999994 110.85 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 85.98 -69.77 3.13 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.761 -0.733 . . . . 51.399999999999999 112.432 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -59.63 -39.43 84.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.795 0.331 . . . . 71.310000000000002 110.867 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -112.73 76.89 2.27 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.61 0.719 . . . . 74.319999999999993 110.83 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.68 -5.55 16.42 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.668 2.246 . . . . 70.319999999999993 112.36 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 11.6 p80 -144.45 23.57 1.62 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.259 -0.428 . . . . 61.420000000000002 110.808 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -99.65 -92.86 2.07 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.721 -0.752 . . . . 74.439999999999998 112.496 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 49.99 -170.16 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.936 0.398 . . . . 71.439999999999998 110.824 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -83.93 -59.87 2.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 52.25 110.912 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.79 -155.36 30.74 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.779 -0.724 . . . . 65.349999999999994 112.447 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -89.4 43.41 1.14 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.9 0.381 . . . . 61.350000000000001 110.947 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 5.4 m -107.13 121.76 45.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 55.210000000000001 110.879 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -103.55 155.81 17.84 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.742 -0.742 . . . . 62.43 112.458 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 5.0 m -88.32 71.13 9.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.857 0.36 . . . . 74.310000000000002 110.886 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.5 pp -47.49 -32.94 5.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.212 -0.449 . . . . 62.43 110.919 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.463 ' O ' HG23 ' A' ' 23' ' ' VAL . 9.9 p -147.29 30.83 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.2 -0.455 . . . . 71.230000000000004 111.163 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 109.66 -31.07 7.85 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.691 -0.766 . . . . 73.010000000000005 112.516 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -101.05 124.23 46.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.965 0.412 . . . . 73.310000000000002 110.852 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 6.8 m -61.33 131.41 50.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.112 -0.495 . . . . 73.400000000000006 110.875 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.465 ' O ' ' CG ' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -142.44 117.03 9.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 73.150000000000006 110.864 -179.894 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -154.09 -133.21 1.77 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.688 -0.768 . . . . 52.399999999999999 112.469 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.3 m -151.17 30.87 0.61 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.853 0.359 . . . . 65.209999999999994 111.158 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -150.39 15.21 0.97 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.775 -0.726 . . . . 21.109999999999999 112.481 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.466 ' OXT' ' O ' ' A' ' 3' ' ' SER . 4.8 m . . . . . 0 C--N 1.328 -0.33 0 CA-C-O 120.775 0.321 . . . . 74.430000000000007 110.905 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 17.6 p . . . . . 0 C--O 1.232 0.179 0 CA-C-O 120.886 0.374 . . . . 73.409999999999997 110.933 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.46 166.66 18.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.282 -0.417 . . . . 71.049999999999997 110.879 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -118.5 19.61 13.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 71.230000000000004 110.827 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 96.9 149.46 25.57 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.751 -0.738 . . . . 70.109999999999999 112.431 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 50.67 26.82 11.1 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.728 -0.749 . . . . 70.209999999999994 112.525 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -106.29 130.09 54.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.764 0.316 . . . . 74.400000000000006 111.1 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -58.52 134.21 56.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 61.219999999999999 110.958 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -126.88 -81.11 0.61 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.265 -0.425 . . . . 73.239999999999995 110.888 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 76.16 -62.61 2.96 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.758 -0.734 . . . . 42.210000000000001 112.481 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -50.43 -34.13 23.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.876 0.369 . . . . 73.129999999999995 110.903 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -146.08 115.87 4.73 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.628 0.728 . . . . 73.099999999999994 110.865 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 -8.01 22.51 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.665 2.243 . . . . 70.010000000000005 112.398 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -128.17 21.28 6.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.21 -0.45 . . . . 72.109999999999999 110.821 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -88.32 65.67 3.36 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.705 -0.759 . . . . 53.210000000000001 112.48 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 12.9 m -138.76 156.9 46.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.82 0.343 . . . . 75.129999999999995 110.94 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -53.5 -61.89 2.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 44.409999999999997 110.883 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.51 -152.26 26.06 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.755 -0.736 . . . . 74.439999999999998 112.517 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -88.79 46.23 1.37 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.854 0.359 . . . . 62.219999999999999 110.874 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.407 ' HA ' ' HA3' ' A' ' 28' ' ' GLY . 62.5 m -91.2 129.69 37.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.229 -0.441 . . . . 74.329999999999998 110.88 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -112.54 150.29 18.31 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.749 -0.738 . . . . 52.539999999999999 112.457 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 38.2 m -89.21 65.2 7.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.903 0.383 . . . . 54.210000000000001 110.87 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -44.77 -36.21 3.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.475 . . . . 74.420000000000002 110.918 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 25.8 t -134.91 8.23 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.465 . . . . 70.510000000000005 111.183 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 117.62 5.19 14.42 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.811 -0.709 . . . . 51.539999999999999 112.509 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -128.39 130.5 47.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.835 0.35 . . . . 73.409999999999997 110.903 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 56.1 m -51.57 124.46 12.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.156 -0.475 . . . . 64.510000000000005 110.84 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -150.52 111.17 4.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 74.329999999999998 110.928 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.407 ' HA3' ' HA ' ' A' ' 19' ' ' CYS . . . -153.78 -127.12 1.15 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.747 -0.739 . . . . 62.43 112.488 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.0 m -150.36 31.08 0.67 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.829 0.347 . . . . 75.519999999999996 111.16 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -138.48 -55.07 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.676 -0.773 . . . . 73.329999999999998 112.491 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.665 ' OXT' ' SG ' ' A' ' 31' ' ' CYS . 14.0 p . . . . . 0 C--N 1.33 -0.246 0 CA-C-O 120.806 0.336 . . . . 70.209999999999994 110.86 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 1.8 p . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.934 0.397 . . . . 64.109999999999999 110.869 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.9 mmpt? -76.15 -168.2 0.89 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.137 -0.483 . . . . 72.010000000000005 110.894 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.2 m -121.67 13.19 10.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.235 -0.439 . . . . 75.329999999999998 110.875 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 92.29 154.33 30.83 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.706 -0.759 . . . . 74.129999999999995 112.495 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 49.84 46.52 40.02 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.76 -0.733 . . . . 70.420000000000002 112.448 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -135.28 148.22 49.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.776 0.322 . . . . 43.039999999999999 111.116 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -64.12 128.79 37.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.16 -0.473 . . . . 73.400000000000006 110.945 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.7 p -117.48 -54.24 2.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.445 . . . . 63.340000000000003 110.876 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 70.57 -81.73 0.39 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.697 -0.763 . . . . 71.549999999999997 112.525 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -60.6 -37.18 80.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.873 0.368 . . . . 73.030000000000001 110.853 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -112.53 75.47 1.8 Allowed Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.608 0.718 . . . . 73.010000000000005 110.885 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.8 -5.84 17.2 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.678 2.252 . . . . 72.400000000000006 112.348 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -142.18 21.75 2.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.224 -0.444 . . . . 70.129999999999995 110.891 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -87.57 -95.07 0.94 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.723 -0.751 . . . . 30.010000000000002 112.453 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 51.07 -171.77 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.886 0.374 . . . . 72.329999999999998 110.84 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -89.14 -57.98 2.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.166 -0.47 . . . . 73.129999999999995 110.927 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.76 -157.08 32.79 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.765 -0.731 . . . . 75.439999999999998 112.478 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -88.44 49.32 1.77 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.841 0.353 . . . . 52.399999999999999 110.863 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.465 ' HA ' ' HA3' ' A' ' 28' ' ' GLY . 86.2 m -102.33 123.5 46.24 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.156 -0.475 . . . . 71.5 110.937 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -100.01 149.55 18.79 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.691 -0.766 . . . . 72.540000000000006 112.57 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 69.3 m -89.11 68.63 8.26 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.807 0.337 . . . . 73.200000000000003 110.862 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -49.29 -31.73 9.59 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.258 -0.428 . . . . 71.209999999999994 110.854 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 3.3 m -142.18 23.48 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.126 -0.488 . . . . 70.129999999999995 111.149 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 109.94 -29.45 9.3 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.753 -0.737 . . . . 75.230000000000004 112.506 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -98.77 130.88 45.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.959 0.409 . . . . 72.230000000000004 110.854 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 87.1 m -57.68 126.91 29.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 64.299999999999997 110.871 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.41 ' O ' ' CG ' ' A' ' 27' ' ' TYR . 0.1 OUTLIER -151.26 111.19 4.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.169 -0.469 . . . . 55.439999999999998 110.856 -179.909 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.465 ' HA3' ' HA ' ' A' ' 19' ' ' CYS . . . -154.81 -123.91 0.88 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.699 -0.762 . . . . 63.340000000000003 112.484 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.0 m -150.8 29.25 0.68 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.83 0.348 . . . . 75.299999999999997 111.11 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -129.54 -65.47 0.11 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.721 -0.752 . . . . 60.229999999999997 112.461 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 21.0 p . . . . . 0 C--N 1.328 -0.355 0 CA-C-O 120.796 0.331 . . . . 52.329999999999998 110.891 -179.872 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 29.5 p . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.896 0.379 . . . . 24.140000000000001 110.883 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.518 ' HB3' ' HB3' ' A' ' 6' ' ' ALA . 0.0 OUTLIER -65.58 143.75 57.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.205 -0.452 . . . . 54.32 110.903 179.924 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -94.47 21.75 6.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.201 -0.454 . . . . 65.409999999999997 110.908 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 92.65 151.66 28.0 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.75 -0.738 . . . . 74.219999999999999 112.489 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 50.89 27.73 14.46 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.701 -0.762 . . . . 63.509999999999998 112.538 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.518 ' HB3' ' HB3' ' A' ' 2' ' ' LYS . . . -108.44 149.36 28.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.803 0.335 . . . . 63.520000000000003 111.135 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -75.32 135.34 40.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 72.209999999999994 110.914 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -131.2 -69.14 0.64 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.245 -0.434 . . . . 71.209999999999994 110.903 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 73.42 -85.79 0.61 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.712 -0.756 . . . . 61.049999999999997 112.52 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -51.32 -34.82 35.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.802 0.334 . . . . 71.340000000000003 110.851 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -111.73 82.4 3.89 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.541 0.686 . . . . 62.310000000000002 110.83 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.87 -7.44 21.08 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.686 2.257 . . . . 65.200000000000003 112.358 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 37.2 m-70 -130.82 21.4 5.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.456 . . . . 71.530000000000001 110.867 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -101.31 85.94 0.59 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.75 -0.738 . . . . 74.549999999999997 112.513 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 61.6 m -143.48 145.76 32.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.843 0.354 . . . . 63.439999999999998 110.964 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -56.84 -55.58 32.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 73.299999999999997 110.843 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.32 -159.74 35.72 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.761 -0.733 . . . . 52.119999999999997 112.458 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -88.46 50.97 2.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.865 0.364 . . . . 74.430000000000007 110.938 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.421 ' HA ' ' HA3' ' A' ' 28' ' ' GLY . 14.3 m -113.76 151.3 32.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.233 -0.44 . . . . 71.219999999999999 110.815 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -129.91 162.44 22.97 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.725 -0.75 . . . . 73.230000000000004 112.484 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 14.6 m -89.18 61.41 5.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.871 0.367 . . . . 65.349999999999994 110.868 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.533 HD22 ' HD2' ' A' ' 27' ' ' TYR . 2.5 pt? -49.77 -29.99 8.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 65.109999999999999 110.856 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.446 ' O ' HG22 ' A' ' 23' ' ' VAL . 7.0 p -142.83 20.45 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 64.239999999999995 111.111 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 108.34 -13.34 36.55 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.668 -0.777 . . . . 34.439999999999998 112.562 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -115.95 135.66 53.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.827 0.346 . . . . 75.329999999999998 110.911 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 17.5 m -64.35 109.6 1.97 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.189 -0.46 . . . . 65.239999999999995 110.874 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.533 ' HD2' HD22 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -128.76 117.59 21.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.191 -0.459 . . . . 71.319999999999993 110.979 -179.922 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.421 ' HA3' ' HA ' ' A' ' 19' ' ' CYS . . . -153.33 -132.84 1.78 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.711 -0.757 . . . . 45.32 112.504 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.9 m -150.33 29.72 0.7 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.787 0.327 . . . . 62.439999999999998 111.153 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -141.09 -55.28 0.04 OUTLIER Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.653 -0.784 . . . . 70.510000000000005 112.441 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 27.6 p . . . . . 0 C--N 1.328 -0.337 0 CA-C-O 120.765 0.316 . . . . 51.32 110.862 -179.834 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 29.0 p . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.947 0.403 . . . . 52.229999999999997 110.898 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.607 ' HB3' ' HB3' ' A' ' 6' ' ' ALA . 0.0 OUTLIER -68.55 125.89 27.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.15 -0.477 . . . . 73.129999999999995 110.828 179.978 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.73 -12.42 61.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 75.120000000000005 110.931 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 131.69 152.13 7.09 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.712 -0.756 . . . . 72.109999999999999 112.455 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 51.6 26.18 15.65 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.741 -0.743 . . . . 75.200000000000003 112.473 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.607 ' HB3' ' HB3' ' A' ' 2' ' ' LYS . . . -103.44 151.54 22.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.753 0.311 . . . . 71.219999999999999 111.104 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -77.85 136.22 38.04 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.257 -0.429 . . . . 74.219999999999999 110.868 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -131.19 -70.45 0.6 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.221 -0.445 . . . . 53.43 110.878 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 75.08 -85.17 0.8 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.65 -0.786 . . . . 61.439999999999998 112.505 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -51.88 -35.97 46.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.855 0.36 . . . . 74.310000000000002 110.856 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -110.58 82.14 2.73 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.621 0.724 . . . . 64.510000000000005 110.897 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -8.56 23.93 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.729 2.286 . . . . 74.409999999999997 112.377 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 7.6 m-70 -128.24 19.3 6.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.246 -0.434 . . . . 71.219999999999999 110.87 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -100.47 88.36 0.76 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.818 -0.706 . . . . 65.510000000000005 112.519 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 65.6 m -144.76 143.83 30.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.866 0.365 . . . . 70.030000000000001 110.867 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -54.61 -56.76 15.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 63.119999999999997 110.927 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.32 -158.6 34.44 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.731 -0.747 . . . . 62.109999999999999 112.567 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -88.69 50.77 2.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.85 0.357 . . . . 73.140000000000001 110.878 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.411 ' HA ' ' HA3' ' A' ' 28' ' ' GLY . 14.2 m -113.5 153.75 28.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.166 -0.47 . . . . 62.130000000000003 110.831 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -132.25 162.51 23.98 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.7 -0.762 . . . . 71.510000000000005 112.471 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 14.2 m -88.97 61.3 5.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.888 0.375 . . . . 74.409999999999997 110.896 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.519 HD22 ' HD2' ' A' ' 27' ' ' TYR . 2.6 pt? -49.67 -30.14 8.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.231 -0.441 . . . . 53.210000000000001 110.919 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.435 ' O ' HG22 ' A' ' 23' ' ' VAL . 6.9 p -143.92 22.8 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.114 -0.494 . . . . 72.019999999999996 111.109 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 107.11 -15.05 40.08 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.732 -0.747 . . . . 51.100000000000001 112.481 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -114.98 135.75 53.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.885 0.374 . . . . 73.319999999999993 110.851 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 15.7 m -65.14 111.0 2.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 71.140000000000001 110.902 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.519 ' HD2' HD22 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -129.28 117.88 21.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.115 -0.493 . . . . 74.140000000000001 110.896 -179.881 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.411 ' HA3' ' HA ' ' A' ' 19' ' ' CYS . . . -153.45 -132.6 1.74 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.771 -0.728 . . . . 73.010000000000005 112.516 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.9 m -150.38 29.55 0.7 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.862 0.363 . . . . 73.420000000000002 111.116 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -141.01 -55.03 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.791 -0.719 . . . . 44.200000000000003 112.547 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 26.9 p . . . . . 0 C--N 1.328 -0.358 0 CA-C-O 120.775 0.322 . . . . 71.140000000000001 110.885 -179.916 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 5.1 p . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.914 0.388 . . . . 75.310000000000002 110.905 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.8 -169.03 0.11 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 74.409999999999997 110.901 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -128.6 20.83 6.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.45 . . . . 72.019999999999996 110.851 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 88.82 152.5 25.56 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.755 -0.736 . . . . 60.030000000000001 112.552 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 51.78 25.49 15.51 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.738 -0.744 . . . . 61.0 112.464 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -107.85 157.23 18.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.778 0.323 . . . . 63.219999999999999 111.119 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -76.71 133.63 39.45 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.197 -0.456 . . . . 71.329999999999998 110.849 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -130.19 -74.14 0.55 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.24 -0.436 . . . . 64.109999999999999 110.875 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.5 -78.27 1.95 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.748 -0.739 . . . . 54.520000000000003 112.427 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -56.65 -34.75 67.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.874 0.368 . . . . 72.319999999999993 110.917 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -112.4 77.22 2.19 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.591 0.71 . . . . 71.219999999999999 110.865 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 -6.4 18.54 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.668 2.246 . . . . 63.32 112.327 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 9.7 p80 -138.06 24.17 2.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.445 . . . . 61.43 110.835 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -121.96 114.44 2.52 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.772 -0.728 . . . . 61.109999999999999 112.493 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -160.92 178.47 9.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.853 0.359 . . . . 70.0 110.872 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -72.4 -22.99 61.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.191 -0.459 . . . . 50.030000000000001 110.808 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -130.52 -162.17 10.61 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.748 -0.739 . . . . 71.239999999999995 112.436 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -88.67 48.51 1.64 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.892 0.377 . . . . 64.329999999999998 110.92 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.412 ' HA ' ' HA3' ' A' ' 28' ' ' GLY . 7.9 m -113.09 127.43 56.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.169 -0.469 . . . . 65.209999999999994 110.879 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -104.57 157.17 16.93 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.8 -0.714 . . . . 70.200000000000003 112.499 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 13.2 m -87.3 65.17 8.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.825 0.345 . . . . 63.009999999999998 110.843 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.466 HD22 ' HD2' ' A' ' 27' ' ' TYR . 2.6 pt? -50.2 -30.41 11.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.117 -0.492 . . . . 64.420000000000002 110.848 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.444 ' O ' HG22 ' A' ' 23' ' ' VAL . 7.5 p -145.0 24.88 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.248 -0.433 . . . . 51.119999999999997 111.142 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 109.17 -23.84 22.21 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.727 -0.749 . . . . 53.200000000000003 112.479 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -106.15 130.5 54.03 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.918 0.389 . . . . 73.010000000000005 110.835 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 1.2 m -65.37 106.93 1.49 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 52.420000000000002 110.904 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.466 ' HD2' HD22 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -121.93 118.93 30.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.156 -0.474 . . . . 73.430000000000007 110.954 -179.908 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.412 ' HA3' ' HA ' ' A' ' 19' ' ' CYS . . . -153.5 -133.21 1.81 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.667 -0.778 . . . . 70.319999999999993 112.47 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.2 m -150.28 31.24 0.68 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.864 0.364 . . . . 74.530000000000001 111.126 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.418 ' O ' ' OXT' ' A' ' 31' ' ' CYS . . . -139.62 -58.47 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.711 -0.757 . . . . 75.510000000000005 112.464 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.418 ' OXT' ' O ' ' A' ' 30' ' ' GLY . 31.3 p . . . . . 0 C--N 1.328 -0.348 0 CA-C-O 120.79 0.329 . . . . 54.409999999999997 110.86 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 5.7 p . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.956 0.408 . . . . 63.329999999999998 110.887 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.62 ' HB3' ' HB3' ' A' ' 6' ' ' ALA . 0.0 OUTLIER -72.07 128.45 35.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 60.009999999999998 110.896 179.961 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -94.41 25.82 3.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 74.430000000000007 110.869 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 100.15 149.45 23.77 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.723 -0.751 . . . . 14.210000000000001 112.476 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 49.76 34.59 21.95 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.796 -0.716 . . . . 61.25 112.433 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.62 ' HB3' ' HB3' ' A' ' 2' ' ' LYS . . . -108.97 143.55 38.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.83 0.347 . . . . 70.129999999999995 111.073 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -72.59 132.32 43.61 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.181 -0.463 . . . . 75.219999999999999 110.999 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -131.35 -69.95 0.61 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.441 . . . . 60.109999999999999 110.825 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 75.14 -85.11 0.81 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.776 -0.726 . . . . 63.210000000000001 112.443 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -52.52 -36.86 56.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.901 0.382 . . . . 65.430000000000007 110.922 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -109.98 85.64 4.32 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.614 0.721 . . . . 73.140000000000001 110.88 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.83 -5.86 17.26 Favored 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.639 2.226 . . . . 64.310000000000002 112.279 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 26.0 m-70 -136.75 23.17 3.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.302 -0.408 . . . . 75.109999999999999 110.85 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -102.67 86.33 0.55 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.778 -0.725 . . . . 74.329999999999998 112.531 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 38.2 m -141.38 162.67 34.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.848 0.356 . . . . 53.229999999999997 110.934 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -60.15 -45.72 92.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.168 -0.469 . . . . 75.200000000000003 110.873 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -111.11 -146.24 10.52 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.748 -0.739 . . . . 72.040000000000006 112.487 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -88.9 41.08 1.01 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.907 0.384 . . . . 65.409999999999997 110.905 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.411 ' HA ' ' HA3' ' A' ' 28' ' ' GLY . 67.8 m -89.48 142.22 27.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 75.140000000000001 110.855 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -126.01 148.85 17.19 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.74 -0.743 . . . . 63.399999999999999 112.498 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 14.1 m -88.73 63.74 7.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.846 0.355 . . . . 70.450000000000003 110.862 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -49.64 -27.98 5.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.187 -0.461 . . . . 74.120000000000005 110.912 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.433 ' O ' HG22 ' A' ' 23' ' ' VAL . 7.1 p -145.31 18.88 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 72.040000000000006 111.162 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 109.65 -10.26 32.62 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.733 -0.746 . . . . 74.510000000000005 112.508 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -115.09 129.45 56.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.906 0.384 . . . . 74.319999999999993 110.879 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 5.8 m -59.18 127.91 34.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.151 -0.477 . . . . 74.510000000000005 110.838 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -150.05 116.87 5.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 75.019999999999996 110.989 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.411 ' HA3' ' HA ' ' A' ' 19' ' ' CYS . . . -154.28 -133.98 1.87 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.754 -0.736 . . . . 53.240000000000002 112.482 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.406 HG22 ' O ' ' A' ' 29' ' ' THR . 3.8 m -150.9 32.79 0.6 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.857 0.36 . . . . 65.310000000000002 111.124 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -150.4 15.79 0.98 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.768 -0.729 . . . . 62.200000000000003 112.502 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 5.6 m . . . . . 0 C--N 1.329 -0.311 0 CA-C-O 120.801 0.334 . . . . 73.319999999999993 110.907 -179.965 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 2.5 p . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.904 0.383 . . . . 62.240000000000002 110.906 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -72.05 -168.66 0.41 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 71.319999999999993 110.886 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -126.78 17.03 7.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 44.030000000000001 110.852 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 87.56 157.08 30.94 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.806 -0.711 . . . . 73.340000000000003 112.488 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 51.83 27.33 20.26 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.718 -0.753 . . . . 74.430000000000007 112.525 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -115.96 155.37 28.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.735 0.302 . . . . 74.409999999999997 111.14 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -74.18 131.38 41.2 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.215 -0.448 . . . . 72.430000000000007 110.891 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -129.5 -76.23 0.55 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.234 -0.439 . . . . 43.030000000000001 110.902 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 84.15 -60.58 4.82 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.713 -0.756 . . . . 64.329999999999998 112.515 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 56.1 p90 -63.21 -38.95 93.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.882 0.373 . . . . 71.349999999999994 110.872 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -116.03 76.14 6.2 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.582 0.706 . . . . 72.129999999999995 110.865 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.75 -5.4 16.12 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.65 2.233 . . . . 72.310000000000002 112.323 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -144.33 24.14 1.61 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 60.149999999999999 110.838 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -105.18 -91.3 2.22 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.697 -0.763 . . . . 30.550000000000001 112.474 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 49.93 -170.45 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.92 0.39 . . . . 54.530000000000001 110.853 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -81.52 -59.16 2.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.475 . . . . 70.519999999999996 110.897 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.73 -156.55 32.13 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.773 -0.727 . . . . 73.329999999999998 112.522 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 11.2 p-10 -88.96 47.8 1.55 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.834 0.349 . . . . 74.519999999999996 110.878 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.413 ' HA ' ' HA3' ' A' ' 28' ' ' GLY . 9.5 m -112.64 138.74 48.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.182 -0.463 . . . . 71.450000000000003 110.87 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -118.8 156.35 15.7 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.728 -0.749 . . . . 71.109999999999999 112.518 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 5.7 m -87.98 65.98 8.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.892 0.377 . . . . 53.119999999999997 110.913 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -49.67 -31.41 10.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.124 -0.489 . . . . 71.430000000000007 110.909 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.471 ' O ' HG22 ' A' ' 23' ' ' VAL . 9.8 p -144.89 28.85 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 64.219999999999999 111.076 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 110.2 -38.59 3.24 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.83 -0.7 . . . . 54.25 112.445 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -96.1 131.27 42.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.862 0.363 . . . . 75.0 110.886 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 1.7 m -64.46 126.15 26.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.248 -0.433 . . . . 74.319999999999993 110.87 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.426 ' O ' ' CG ' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -137.42 118.53 14.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 71.549999999999997 110.943 -179.931 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.413 ' HA3' ' HA ' ' A' ' 19' ' ' CYS . . . -153.98 -134.33 1.94 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.758 -0.734 . . . . 63.32 112.51 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.1 m -150.14 30.67 0.7 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.782 0.325 . . . . 64.120000000000005 111.179 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -140.38 -55.4 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.782 -0.723 . . . . 64.310000000000002 112.526 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 27.1 p . . . . . 0 C--N 1.328 -0.337 0 CA-C-O 120.817 0.342 . . . . 64.25 110.829 -179.866 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 5.2 p . . . . . 0 C--O 1.232 0.18 0 CA-C-O 120.921 0.391 . . . . 72.549999999999997 110.835 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.691 ' HB3' ' HB3' ' A' ' 6' ' ' ALA . 0.0 OUTLIER -73.77 142.24 46.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 73.230000000000004 110.82 179.922 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -98.73 20.43 13.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.173 -0.467 . . . . 72.25 110.876 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 101.82 150.03 22.99 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.783 -0.722 . . . . 73.120000000000005 112.47 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 49.93 29.45 14.0 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.745 -0.741 . . . . 75.349999999999994 112.459 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.691 ' HB3' ' HB3' ' A' ' 2' ' ' LYS . . . -107.99 129.69 55.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.747 0.308 . . . . 74.129999999999995 111.116 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -59.58 132.62 54.55 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.261 -0.427 . . . . 74.329999999999998 110.925 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -128.48 -73.04 0.59 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 75.420000000000002 110.869 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 78.33 -83.16 1.22 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.744 -0.741 . . . . 74.209999999999994 112.454 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -53.68 -34.56 59.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.845 0.355 . . . . 71.439999999999998 110.897 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -113.16 85.67 8.54 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.654 0.74 . . . . 64.049999999999997 110.85 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.82 -8.08 22.7 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.731 2.287 . . . . 65.120000000000005 112.33 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 25.6 p80 -133.02 21.51 4.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 72.209999999999994 110.875 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -99.35 86.33 0.7 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.743 -0.741 . . . . 74.450000000000003 112.555 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 52.6 m -141.9 154.8 45.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.841 0.353 . . . . 73.430000000000007 110.932 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -72.99 -22.39 60.69 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.171 -0.468 . . . . 74.540000000000006 110.875 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -121.27 -159.51 10.74 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.806 -0.711 . . . . 64.230000000000004 112.496 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -89.3 48.58 1.63 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.873 0.368 . . . . 74.150000000000006 110.861 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.466 ' HA ' ' HA3' ' A' ' 28' ' ' GLY . 6.5 m -110.54 149.83 29.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 62.25 110.858 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -127.71 156.9 20.79 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.693 -0.765 . . . . 52.25 112.49 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 22.4 m -88.88 57.94 4.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.875 0.369 . . . . 74.329999999999998 110.893 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.548 ' HG ' HG22 ' A' ' 23' ' ' VAL . 2.5 pt? -48.09 -33.97 8.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.194 -0.457 . . . . 74.430000000000007 110.922 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.622 HG23 ' CD2' ' A' ' 25' ' ' PHE . 1.8 m -133.3 9.63 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.471 . . . . 75.340000000000003 111.053 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 116.01 -7.52 19.19 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.679 -0.772 . . . . 53.119999999999997 112.449 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.622 ' CD2' HG23 ' A' ' 23' ' ' VAL . 1.3 m-85 -119.6 136.08 54.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.919 0.39 . . . . 74.329999999999998 110.877 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 11.9 m -63.26 102.37 0.39 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.137 -0.483 . . . . 73.430000000000007 110.905 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.546 ' HD2' HD22 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -118.75 115.07 23.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 74.299999999999997 110.892 -179.801 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.466 ' HA3' ' HA ' ' A' ' 19' ' ' CYS . . . -154.22 -140.02 2.95 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.767 -0.73 . . . . 61.240000000000002 112.522 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 4.0 m -150.82 36.89 0.63 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.796 0.331 . . . . 54.32 111.099 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -146.66 -38.06 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.696 -0.764 . . . . 62.020000000000003 112.436 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 33.3 m . . . . . 0 C--N 1.328 -0.335 0 CA-C-O 120.786 0.327 . . . . 74.530000000000001 110.856 -179.863 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 2.6 p . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.937 0.399 . . . . 44.43 110.845 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.48 -167.96 0.05 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.158 -0.474 . . . . 74.129999999999995 110.896 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -129.01 18.84 6.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.231 -0.441 . . . . 54.049999999999997 110.869 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 86.1 157.0 28.77 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.726 -0.75 . . . . 73.400000000000006 112.52 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 51.96 26.73 19.64 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.81 -0.709 . . . . 73.099999999999994 112.503 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -114.79 155.87 25.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.8 0.334 . . . . 75.219999999999999 111.111 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -74.48 131.08 40.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.155 -0.475 . . . . 64.019999999999996 110.905 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -128.23 -75.95 0.56 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.258 -0.428 . . . . 71.409999999999997 110.967 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 85.08 -64.71 4.18 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.705 -0.76 . . . . 33.229999999999997 112.492 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 55.7 p90 -61.65 -39.27 90.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.932 0.396 . . . . 75.340000000000003 110.873 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -114.43 76.52 3.85 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.595 0.712 . . . . 42.420000000000002 110.839 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.74 -5.37 16.04 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.7 2.267 . . . . 73.030000000000001 112.372 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 11.3 p80 -144.9 23.26 1.56 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 74.150000000000006 110.9 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -101.65 -92.34 2.17 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.72 -0.752 . . . . 44.409999999999997 112.451 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 50.29 -171.2 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.878 0.371 . . . . 65.519999999999996 110.881 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -78.27 -62.26 1.74 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 63.340000000000003 110.858 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.66 -153.16 27.66 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.744 -0.741 . . . . 55.299999999999997 112.51 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -89.03 46.36 1.38 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.933 0.396 . . . . 75.319999999999993 110.875 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.419 ' HA ' ' HA3' ' A' ' 28' ' ' GLY . 34.0 m -107.38 134.95 49.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.125 -0.489 . . . . 72.340000000000003 110.835 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -117.57 154.26 16.77 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.699 -0.762 . . . . 71.209999999999994 112.482 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 5.4 m -88.13 67.4 8.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.89 0.376 . . . . 71.120000000000005 110.939 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -50.54 -27.99 7.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.469 . . . . 60.399999999999999 110.918 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.466 ' O ' HG22 ' A' ' 23' ' ' VAL . 9.5 p -148.01 28.28 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 73.549999999999997 111.151 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 109.9 -36.34 4.35 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.767 -0.73 . . . . 62.020000000000003 112.46 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -97.52 129.18 44.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.951 0.405 . . . . 61.340000000000003 110.825 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 2.7 m -62.65 130.32 44.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.47 . . . . 70.340000000000003 110.867 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.44 ' O ' ' CG ' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -142.84 117.88 10.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.129 -0.487 . . . . 70.400000000000006 110.975 -179.882 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.419 ' HA3' ' HA ' ' A' ' 19' ' ' CYS . . . -153.9 -132.26 1.66 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.729 -0.748 . . . . 33.030000000000001 112.503 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.0 m -150.36 29.27 0.71 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.84 0.352 . . . . 75.040000000000006 111.153 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.548 ' O ' ' OXT' ' A' ' 31' ' ' CYS . . . -138.11 -56.93 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.743 -0.741 . . . . 61.009999999999998 112.497 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.548 ' OXT' ' O ' ' A' ' 30' ' ' GLY . 29.9 p . . . . . 0 C--N 1.329 -0.291 0 CA-C-O 120.785 0.326 . . . . 62.140000000000001 110.846 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 2.6 p . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.829 0.347 . . . . 72.409999999999997 110.892 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.18 -168.8 0.68 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.192 -0.458 . . . . 73.010000000000005 110.878 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.466 ' O ' ' OXT' ' A' ' 31' ' ' CYS . 0.5 OUTLIER -130.64 18.73 5.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.45 . . . . 71.0 110.855 -179.887 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 95.44 155.92 31.49 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.667 -0.777 . . . . 42.530000000000001 112.478 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 51.64 27.49 19.18 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.825 -0.703 . . . . 51.329999999999998 112.423 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -113.29 149.61 33.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.792 0.33 . . . . 52.210000000000001 111.097 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -70.59 131.38 43.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.174 -0.466 . . . . 74.219999999999999 110.949 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -129.19 -76.11 0.55 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.228 -0.442 . . . . 75.209999999999994 110.85 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 85.98 -69.77 3.13 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.761 -0.733 . . . . 51.399999999999999 112.432 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -59.63 -39.43 84.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.795 0.331 . . . . 71.310000000000002 110.867 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -112.73 76.89 2.27 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.61 0.719 . . . . 74.319999999999993 110.83 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.68 -5.55 16.42 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.668 2.246 . . . . 70.319999999999993 112.36 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 11.6 p80 -144.45 23.57 1.62 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.259 -0.428 . . . . 61.420000000000002 110.808 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -99.65 -92.86 2.07 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.721 -0.752 . . . . 74.439999999999998 112.496 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 49.99 -170.16 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.936 0.398 . . . . 71.439999999999998 110.824 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -83.93 -59.87 2.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 52.25 110.912 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.79 -155.36 30.74 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.779 -0.724 . . . . 65.349999999999994 112.447 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -89.4 43.41 1.14 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.9 0.381 . . . . 61.350000000000001 110.947 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 5.4 m -107.13 121.76 45.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 55.210000000000001 110.879 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -103.55 155.81 17.84 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.742 -0.742 . . . . 62.43 112.458 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 5.0 m -88.32 71.13 9.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.857 0.36 . . . . 74.310000000000002 110.886 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.411 HD23 ' CD2' ' A' ' 27' ' ' TYR . 1.5 pp -47.49 -32.94 5.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.212 -0.449 . . . . 62.43 110.919 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.469 ' O ' HG22 ' A' ' 23' ' ' VAL . 9.9 p -147.29 30.83 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.2 -0.455 . . . . 71.230000000000004 111.163 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 109.66 -31.07 7.85 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.691 -0.766 . . . . 73.010000000000005 112.516 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -101.05 124.23 46.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.965 0.412 . . . . 73.310000000000002 110.852 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 6.8 m -61.33 131.41 50.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.112 -0.495 . . . . 73.400000000000006 110.875 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.465 ' O ' ' CG ' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -142.44 117.03 9.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 73.150000000000006 110.864 -179.894 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -154.09 -133.21 1.77 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.688 -0.768 . . . . 52.399999999999999 112.469 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.3 m -151.17 30.87 0.61 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.853 0.359 . . . . 65.209999999999994 111.158 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -150.39 15.21 0.97 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.775 -0.726 . . . . 21.109999999999999 112.481 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.466 ' OXT' ' O ' ' A' ' 3' ' ' SER . 4.8 m . . . . . 0 C--N 1.328 -0.33 0 CA-C-O 120.775 0.321 . . . . 74.430000000000007 110.905 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 17.6 p . . . . . 0 C--O 1.232 0.179 0 CA-C-O 120.886 0.374 . . . . 73.409999999999997 110.933 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.46 166.66 18.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.282 -0.417 . . . . 71.049999999999997 110.879 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -118.5 19.61 13.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 71.230000000000004 110.827 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 96.9 149.46 25.57 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.751 -0.738 . . . . 70.109999999999999 112.431 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 50.67 26.82 11.1 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.728 -0.749 . . . . 70.209999999999994 112.525 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -106.29 130.09 54.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.764 0.316 . . . . 74.400000000000006 111.1 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -58.52 134.21 56.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 61.219999999999999 110.958 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -126.88 -81.11 0.61 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.265 -0.425 . . . . 73.239999999999995 110.888 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 76.16 -62.61 2.96 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.758 -0.734 . . . . 42.210000000000001 112.481 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -50.43 -34.13 23.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.876 0.369 . . . . 73.129999999999995 110.903 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -146.08 115.87 4.73 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.628 0.728 . . . . 73.099999999999994 110.865 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 -8.01 22.51 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.665 2.243 . . . . 70.010000000000005 112.398 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -128.17 21.28 6.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.21 -0.45 . . . . 72.109999999999999 110.821 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -88.32 65.67 3.36 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.705 -0.759 . . . . 53.210000000000001 112.48 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 12.9 m -138.76 156.9 46.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.82 0.343 . . . . 75.129999999999995 110.94 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -53.5 -61.89 2.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 44.409999999999997 110.883 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.51 -152.26 26.06 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.755 -0.736 . . . . 74.439999999999998 112.517 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.5 p-10 -88.79 46.23 1.37 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.854 0.359 . . . . 62.219999999999999 110.874 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.41 ' HA ' ' HA3' ' A' ' 28' ' ' GLY . 62.5 m -91.2 129.69 37.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.229 -0.441 . . . . 74.329999999999998 110.88 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -112.54 150.29 18.31 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.749 -0.738 . . . . 52.539999999999999 112.457 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 38.2 m -89.21 65.2 7.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.903 0.383 . . . . 54.210000000000001 110.87 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.897 ' HG ' HG23 ' A' ' 23' ' ' VAL . 2.6 pt? -44.77 -36.21 3.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.475 . . . . 74.420000000000002 110.918 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.897 HG23 ' HG ' ' A' ' 22' ' ' LEU . 25.8 t -134.91 8.23 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.465 . . . . 70.510000000000005 111.183 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 117.62 5.19 14.42 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.811 -0.709 . . . . 51.539999999999999 112.509 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -128.39 130.5 47.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.835 0.35 . . . . 73.409999999999997 110.903 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 56.1 m -51.57 124.46 12.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.156 -0.475 . . . . 64.510000000000005 110.84 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.433 ' CD2' HD22 ' A' ' 22' ' ' LEU . 0.3 OUTLIER -150.52 111.17 4.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 74.329999999999998 110.928 -179.937 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.41 ' HA3' ' HA ' ' A' ' 19' ' ' CYS . . . -153.78 -127.12 1.15 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.747 -0.739 . . . . 62.43 112.488 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.0 m -150.36 31.08 0.67 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.829 0.347 . . . . 75.519999999999996 111.16 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -138.48 -55.07 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.676 -0.773 . . . . 73.329999999999998 112.491 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.665 ' OXT' ' SG ' ' A' ' 31' ' ' CYS . 14.0 p . . . . . 0 C--N 1.33 -0.246 0 CA-C-O 120.806 0.336 . . . . 70.209999999999994 110.86 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 1.8 p . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.934 0.397 . . . . 64.109999999999999 110.869 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.9 mmpt? -76.15 -168.2 0.89 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.137 -0.483 . . . . 72.010000000000005 110.894 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.2 m -121.67 13.19 10.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.235 -0.439 . . . . 75.329999999999998 110.875 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 92.29 154.33 30.83 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.706 -0.759 . . . . 74.129999999999995 112.495 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 49.84 46.52 40.02 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.76 -0.733 . . . . 70.420000000000002 112.448 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -135.28 148.22 49.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.776 0.322 . . . . 43.039999999999999 111.116 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -64.12 128.79 37.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.16 -0.473 . . . . 73.400000000000006 110.945 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.7 p -117.48 -54.24 2.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.445 . . . . 63.340000000000003 110.876 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 70.57 -81.73 0.39 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.697 -0.763 . . . . 71.549999999999997 112.525 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -60.6 -37.18 80.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.873 0.368 . . . . 73.030000000000001 110.853 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -112.53 75.47 1.8 Allowed Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.608 0.718 . . . . 73.010000000000005 110.885 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.8 -5.84 17.2 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.678 2.252 . . . . 72.400000000000006 112.348 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -142.18 21.75 2.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.224 -0.444 . . . . 70.129999999999995 110.891 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -87.57 -95.07 0.94 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.723 -0.751 . . . . 30.010000000000002 112.453 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 51.07 -171.77 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.886 0.374 . . . . 72.329999999999998 110.84 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -89.14 -57.98 2.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.166 -0.47 . . . . 73.129999999999995 110.927 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.76 -157.08 32.79 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.765 -0.731 . . . . 75.439999999999998 112.478 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -88.44 49.32 1.77 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.841 0.353 . . . . 52.399999999999999 110.863 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.466 ' HA ' ' HA3' ' A' ' 28' ' ' GLY . 86.2 m -102.33 123.5 46.24 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.156 -0.475 . . . . 71.5 110.937 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -100.01 149.55 18.79 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.691 -0.766 . . . . 72.540000000000006 112.57 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 69.3 m -89.11 68.63 8.26 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.807 0.337 . . . . 73.200000000000003 110.862 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.61 ' HG ' HG22 ' A' ' 23' ' ' VAL . 2.5 pt? -49.29 -31.73 9.59 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.258 -0.428 . . . . 71.209999999999994 110.854 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.61 HG22 ' HG ' ' A' ' 22' ' ' LEU . 3.3 m -142.18 23.48 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.126 -0.488 . . . . 70.129999999999995 111.149 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 109.94 -29.45 9.3 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.753 -0.737 . . . . 75.230000000000004 112.506 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.49 ' CD2' HG23 ' A' ' 23' ' ' VAL . 0.6 OUTLIER -98.77 130.88 45.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.959 0.409 . . . . 72.230000000000004 110.854 -179.868 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 87.1 m -57.68 126.91 29.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 64.299999999999997 110.871 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.486 ' HD2' HD22 ' A' ' 22' ' ' LEU . 0.1 OUTLIER -151.26 111.19 4.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.169 -0.469 . . . . 55.439999999999998 110.856 -179.909 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.466 ' HA3' ' HA ' ' A' ' 19' ' ' CYS . . . -154.81 -123.91 0.88 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.699 -0.762 . . . . 63.340000000000003 112.484 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.0 m -150.8 29.25 0.68 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.83 0.348 . . . . 75.299999999999997 111.11 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -129.54 -65.47 0.11 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.721 -0.752 . . . . 60.229999999999997 112.461 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 21.0 p . . . . . 0 C--N 1.328 -0.355 0 CA-C-O 120.796 0.331 . . . . 52.329999999999998 110.891 -179.872 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 29.5 p . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.896 0.379 . . . . 24.140000000000001 110.883 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.518 ' HB3' ' HB3' ' A' ' 6' ' ' ALA . 0.0 OUTLIER -65.58 143.75 57.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.205 -0.452 . . . . 54.32 110.903 179.924 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -94.47 21.75 6.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.201 -0.454 . . . . 65.409999999999997 110.908 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 92.65 151.66 28.0 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.75 -0.738 . . . . 74.219999999999999 112.489 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 50.89 27.73 14.46 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.701 -0.762 . . . . 63.509999999999998 112.538 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.518 ' HB3' ' HB3' ' A' ' 2' ' ' LYS . . . -108.44 149.36 28.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.803 0.335 . . . . 63.520000000000003 111.135 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -75.32 135.34 40.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 72.209999999999994 110.914 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -131.2 -69.14 0.64 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.245 -0.434 . . . . 71.209999999999994 110.903 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 73.42 -85.79 0.61 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.712 -0.756 . . . . 61.049999999999997 112.52 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -51.32 -34.82 35.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.802 0.334 . . . . 71.340000000000003 110.851 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -111.73 82.4 3.89 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.541 0.686 . . . . 62.310000000000002 110.83 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.87 -7.44 21.08 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.686 2.257 . . . . 65.200000000000003 112.358 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 37.2 m-70 -130.82 21.4 5.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.456 . . . . 71.530000000000001 110.867 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -101.31 85.94 0.59 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.75 -0.738 . . . . 74.549999999999997 112.513 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 61.6 m -143.48 145.76 32.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.843 0.354 . . . . 63.439999999999998 110.964 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -56.84 -55.58 32.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 73.299999999999997 110.843 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.32 -159.74 35.72 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.761 -0.733 . . . . 52.119999999999997 112.458 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -88.46 50.97 2.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.865 0.364 . . . . 74.430000000000007 110.938 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.421 ' HA ' ' HA3' ' A' ' 28' ' ' GLY . 14.3 m -113.76 151.3 32.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.233 -0.44 . . . . 71.219999999999999 110.815 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -129.91 162.44 22.97 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.725 -0.75 . . . . 73.230000000000004 112.484 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 14.6 m -89.18 61.41 5.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.871 0.367 . . . . 65.349999999999994 110.868 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.533 HD22 ' HD2' ' A' ' 27' ' ' TYR . 2.5 pt? -49.77 -29.99 8.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 65.109999999999999 110.856 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.446 ' O ' HG22 ' A' ' 23' ' ' VAL . 7.0 p -142.83 20.45 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 64.239999999999995 111.111 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 108.34 -13.34 36.55 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.668 -0.777 . . . . 34.439999999999998 112.562 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -115.95 135.66 53.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.827 0.346 . . . . 75.329999999999998 110.911 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 17.5 m -64.35 109.6 1.97 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.189 -0.46 . . . . 65.239999999999995 110.874 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.533 ' HD2' HD22 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -128.76 117.59 21.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.191 -0.459 . . . . 71.319999999999993 110.979 -179.922 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.421 ' HA3' ' HA ' ' A' ' 19' ' ' CYS . . . -153.33 -132.84 1.78 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.711 -0.757 . . . . 45.32 112.504 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.9 m -150.33 29.72 0.7 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.787 0.327 . . . . 62.439999999999998 111.153 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -141.09 -55.28 0.04 OUTLIER Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.653 -0.784 . . . . 70.510000000000005 112.441 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 27.6 p . . . . . 0 C--N 1.328 -0.337 0 CA-C-O 120.765 0.316 . . . . 51.32 110.862 -179.834 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 29.0 p . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.947 0.403 . . . . 52.229999999999997 110.898 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.607 ' HB3' ' HB3' ' A' ' 6' ' ' ALA . 0.0 OUTLIER -68.55 125.89 27.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.15 -0.477 . . . . 73.129999999999995 110.828 179.978 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.73 -12.42 61.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 75.120000000000005 110.931 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 131.69 152.13 7.09 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.712 -0.756 . . . . 72.109999999999999 112.455 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 51.6 26.18 15.65 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.741 -0.743 . . . . 75.200000000000003 112.473 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.607 ' HB3' ' HB3' ' A' ' 2' ' ' LYS . . . -103.44 151.54 22.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.753 0.311 . . . . 71.219999999999999 111.104 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -77.85 136.22 38.04 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.257 -0.429 . . . . 74.219999999999999 110.868 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -131.19 -70.45 0.6 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.221 -0.445 . . . . 53.43 110.878 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 75.08 -85.17 0.8 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.65 -0.786 . . . . 61.439999999999998 112.505 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -51.88 -35.97 46.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.855 0.36 . . . . 74.310000000000002 110.856 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -110.58 82.14 2.73 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.621 0.724 . . . . 64.510000000000005 110.897 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -8.56 23.93 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.729 2.286 . . . . 74.409999999999997 112.377 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 7.6 m-70 -128.24 19.3 6.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.246 -0.434 . . . . 71.219999999999999 110.87 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -100.47 88.36 0.76 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.818 -0.706 . . . . 65.510000000000005 112.519 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 65.6 m -144.76 143.83 30.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.866 0.365 . . . . 70.030000000000001 110.867 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -54.61 -56.76 15.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 63.119999999999997 110.927 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.32 -158.6 34.44 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.731 -0.747 . . . . 62.109999999999999 112.567 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -88.69 50.77 2.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.85 0.357 . . . . 73.140000000000001 110.878 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.411 ' HA ' ' HA3' ' A' ' 28' ' ' GLY . 14.2 m -113.5 153.75 28.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.166 -0.47 . . . . 62.130000000000003 110.831 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -132.25 162.51 23.98 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.7 -0.762 . . . . 71.510000000000005 112.471 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 14.2 m -88.97 61.3 5.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.888 0.375 . . . . 74.409999999999997 110.896 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.519 HD22 ' HD2' ' A' ' 27' ' ' TYR . 2.6 pt? -49.67 -30.14 8.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.231 -0.441 . . . . 53.210000000000001 110.919 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.435 ' O ' HG22 ' A' ' 23' ' ' VAL . 6.9 p -143.92 22.8 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.114 -0.494 . . . . 72.019999999999996 111.109 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 107.11 -15.05 40.08 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.732 -0.747 . . . . 51.100000000000001 112.481 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -114.98 135.75 53.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.885 0.374 . . . . 73.319999999999993 110.851 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 15.7 m -65.14 111.0 2.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 71.140000000000001 110.902 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.519 ' HD2' HD22 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -129.28 117.88 21.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.115 -0.493 . . . . 74.140000000000001 110.896 -179.881 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.411 ' HA3' ' HA ' ' A' ' 19' ' ' CYS . . . -153.45 -132.6 1.74 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.771 -0.728 . . . . 73.010000000000005 112.516 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.9 m -150.38 29.55 0.7 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.862 0.363 . . . . 73.420000000000002 111.116 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -141.01 -55.03 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.791 -0.719 . . . . 44.200000000000003 112.547 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 26.9 p . . . . . 0 C--N 1.328 -0.358 0 CA-C-O 120.775 0.322 . . . . 71.140000000000001 110.885 -179.916 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 5.1 p . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.914 0.388 . . . . 75.310000000000002 110.905 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.8 -169.03 0.11 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 74.409999999999997 110.901 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -128.6 20.83 6.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.45 . . . . 72.019999999999996 110.851 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 88.82 152.5 25.56 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.755 -0.736 . . . . 60.030000000000001 112.552 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 51.78 25.49 15.51 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.738 -0.744 . . . . 61.0 112.464 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -107.85 157.23 18.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.778 0.323 . . . . 63.219999999999999 111.119 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -76.71 133.63 39.45 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.197 -0.456 . . . . 71.329999999999998 110.849 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -130.19 -74.14 0.55 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.24 -0.436 . . . . 64.109999999999999 110.875 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.5 -78.27 1.95 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.748 -0.739 . . . . 54.520000000000003 112.427 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -56.65 -34.75 67.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.874 0.368 . . . . 72.319999999999993 110.917 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -112.4 77.22 2.19 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.591 0.71 . . . . 71.219999999999999 110.865 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 -6.4 18.54 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.668 2.246 . . . . 63.32 112.327 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 9.7 p80 -138.06 24.17 2.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.445 . . . . 61.43 110.835 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -121.96 114.44 2.52 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.772 -0.728 . . . . 61.109999999999999 112.493 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -160.92 178.47 9.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.853 0.359 . . . . 70.0 110.872 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -72.4 -22.99 61.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.191 -0.459 . . . . 50.030000000000001 110.808 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -130.52 -162.17 10.61 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.748 -0.739 . . . . 71.239999999999995 112.436 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -88.67 48.51 1.64 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.892 0.377 . . . . 64.329999999999998 110.92 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.412 ' HA ' ' HA3' ' A' ' 28' ' ' GLY . 7.9 m -113.09 127.43 56.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.169 -0.469 . . . . 65.209999999999994 110.879 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -104.57 157.17 16.93 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.8 -0.714 . . . . 70.200000000000003 112.499 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 13.2 m -87.3 65.17 8.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.825 0.345 . . . . 63.009999999999998 110.843 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.466 HD22 ' HD2' ' A' ' 27' ' ' TYR . 2.6 pt? -50.2 -30.41 11.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.117 -0.492 . . . . 64.420000000000002 110.848 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.444 ' O ' HG22 ' A' ' 23' ' ' VAL . 7.5 p -145.0 24.88 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.248 -0.433 . . . . 51.119999999999997 111.142 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 109.17 -23.84 22.21 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.727 -0.749 . . . . 53.200000000000003 112.479 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -106.15 130.5 54.03 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.918 0.389 . . . . 73.010000000000005 110.835 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 1.2 m -65.37 106.93 1.49 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 52.420000000000002 110.904 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.466 ' HD2' HD22 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -121.93 118.93 30.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.156 -0.474 . . . . 73.430000000000007 110.954 -179.908 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.412 ' HA3' ' HA ' ' A' ' 19' ' ' CYS . . . -153.5 -133.21 1.81 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.667 -0.778 . . . . 70.319999999999993 112.47 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.2 m -150.28 31.24 0.68 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.864 0.364 . . . . 74.530000000000001 111.126 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.418 ' O ' ' OXT' ' A' ' 31' ' ' CYS . . . -139.62 -58.47 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.711 -0.757 . . . . 75.510000000000005 112.464 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.418 ' OXT' ' O ' ' A' ' 30' ' ' GLY . 31.3 p . . . . . 0 C--N 1.328 -0.348 0 CA-C-O 120.79 0.329 . . . . 54.409999999999997 110.86 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 5.7 p . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.956 0.408 . . . . 63.329999999999998 110.887 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.62 ' HB3' ' HB3' ' A' ' 6' ' ' ALA . 0.0 OUTLIER -72.07 128.45 35.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 60.009999999999998 110.896 179.961 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -94.41 25.82 3.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 74.430000000000007 110.869 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 100.15 149.45 23.77 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.723 -0.751 . . . . 14.210000000000001 112.476 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 49.76 34.59 21.95 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.796 -0.716 . . . . 61.25 112.433 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.62 ' HB3' ' HB3' ' A' ' 2' ' ' LYS . . . -108.97 143.55 38.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.83 0.347 . . . . 70.129999999999995 111.073 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -72.59 132.32 43.61 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.181 -0.463 . . . . 75.219999999999999 110.999 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -131.35 -69.95 0.61 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.441 . . . . 60.109999999999999 110.825 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 75.14 -85.11 0.81 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.776 -0.726 . . . . 63.210000000000001 112.443 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -52.52 -36.86 56.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.901 0.382 . . . . 65.430000000000007 110.922 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -109.98 85.64 4.32 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.614 0.721 . . . . 73.140000000000001 110.88 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.83 -5.86 17.26 Favored 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.639 2.226 . . . . 64.310000000000002 112.279 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 26.0 m-70 -136.75 23.17 3.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.302 -0.408 . . . . 75.109999999999999 110.85 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -102.67 86.33 0.55 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.778 -0.725 . . . . 74.329999999999998 112.531 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 38.2 m -141.38 162.67 34.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.848 0.356 . . . . 53.229999999999997 110.934 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -60.15 -45.72 92.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.168 -0.469 . . . . 75.200000000000003 110.873 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -111.11 -146.24 10.52 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.748 -0.739 . . . . 72.040000000000006 112.487 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -88.9 41.08 1.01 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.907 0.384 . . . . 65.409999999999997 110.905 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.411 ' HA ' ' HA3' ' A' ' 28' ' ' GLY . 67.8 m -89.48 142.22 27.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 75.140000000000001 110.855 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -126.01 148.85 17.19 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.74 -0.743 . . . . 63.399999999999999 112.498 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 14.1 m -88.73 63.74 7.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.846 0.355 . . . . 70.450000000000003 110.862 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -49.64 -27.98 5.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.187 -0.461 . . . . 74.120000000000005 110.912 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.433 ' O ' HG22 ' A' ' 23' ' ' VAL . 7.1 p -145.31 18.88 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 72.040000000000006 111.162 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 109.65 -10.26 32.62 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.733 -0.746 . . . . 74.510000000000005 112.508 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -115.09 129.45 56.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.906 0.384 . . . . 74.319999999999993 110.879 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 5.8 m -59.18 127.91 34.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.151 -0.477 . . . . 74.510000000000005 110.838 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -150.05 116.87 5.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 75.019999999999996 110.989 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.411 ' HA3' ' HA ' ' A' ' 19' ' ' CYS . . . -154.28 -133.98 1.87 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.754 -0.736 . . . . 53.240000000000002 112.482 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.406 HG22 ' O ' ' A' ' 29' ' ' THR . 3.8 m -150.9 32.79 0.6 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.857 0.36 . . . . 65.310000000000002 111.124 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -150.4 15.79 0.98 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.768 -0.729 . . . . 62.200000000000003 112.502 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 5.6 m . . . . . 0 C--N 1.329 -0.311 0 CA-C-O 120.801 0.334 . . . . 73.319999999999993 110.907 -179.965 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 2.5 p . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.904 0.383 . . . . 62.240000000000002 110.906 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -72.05 -168.66 0.41 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 71.319999999999993 110.886 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -126.78 17.03 7.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 44.030000000000001 110.852 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 87.56 157.08 30.94 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.806 -0.711 . . . . 73.340000000000003 112.488 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 51.83 27.33 20.26 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.718 -0.753 . . . . 74.430000000000007 112.525 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -115.96 155.37 28.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.735 0.302 . . . . 74.409999999999997 111.14 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -74.18 131.38 41.2 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.215 -0.448 . . . . 72.430000000000007 110.891 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -129.5 -76.23 0.55 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.234 -0.439 . . . . 43.030000000000001 110.902 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 84.15 -60.58 4.82 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.713 -0.756 . . . . 64.329999999999998 112.515 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 56.1 p90 -63.21 -38.95 93.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.882 0.373 . . . . 71.349999999999994 110.872 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -116.03 76.14 6.2 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.582 0.706 . . . . 72.129999999999995 110.865 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.75 -5.4 16.12 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.65 2.233 . . . . 72.310000000000002 112.323 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -144.33 24.14 1.61 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 60.149999999999999 110.838 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -105.18 -91.3 2.22 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.697 -0.763 . . . . 30.550000000000001 112.474 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 49.93 -170.45 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.92 0.39 . . . . 54.530000000000001 110.853 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -81.52 -59.16 2.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.475 . . . . 70.519999999999996 110.897 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.73 -156.55 32.13 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.773 -0.727 . . . . 73.329999999999998 112.522 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 11.2 p-10 -88.96 47.8 1.55 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.834 0.349 . . . . 74.519999999999996 110.878 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.413 ' HA ' ' HA3' ' A' ' 28' ' ' GLY . 9.5 m -112.64 138.74 48.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.182 -0.463 . . . . 71.450000000000003 110.87 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -118.8 156.35 15.7 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.728 -0.749 . . . . 71.109999999999999 112.518 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 5.7 m -87.98 65.98 8.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.892 0.377 . . . . 53.119999999999997 110.913 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -49.67 -31.41 10.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.124 -0.489 . . . . 71.430000000000007 110.909 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.471 ' O ' HG22 ' A' ' 23' ' ' VAL . 9.8 p -144.89 28.85 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 64.219999999999999 111.076 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 110.2 -38.59 3.24 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.83 -0.7 . . . . 54.25 112.445 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -96.1 131.27 42.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.862 0.363 . . . . 75.0 110.886 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 1.7 m -64.46 126.15 26.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.248 -0.433 . . . . 74.319999999999993 110.87 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.426 ' O ' ' CG ' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -137.42 118.53 14.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 71.549999999999997 110.943 -179.931 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.413 ' HA3' ' HA ' ' A' ' 19' ' ' CYS . . . -153.98 -134.33 1.94 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.758 -0.734 . . . . 63.32 112.51 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.1 m -150.14 30.67 0.7 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.782 0.325 . . . . 64.120000000000005 111.179 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -140.38 -55.4 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.782 -0.723 . . . . 64.310000000000002 112.526 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 27.1 p . . . . . 0 C--N 1.328 -0.337 0 CA-C-O 120.817 0.342 . . . . 64.25 110.829 -179.866 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 5.2 p . . . . . 0 C--O 1.232 0.18 0 CA-C-O 120.921 0.391 . . . . 72.549999999999997 110.835 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.691 ' HB3' ' HB3' ' A' ' 6' ' ' ALA . 0.0 OUTLIER -73.77 142.24 46.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 73.230000000000004 110.82 179.922 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -98.73 20.43 13.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.173 -0.467 . . . . 72.25 110.876 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 101.82 150.03 22.99 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.783 -0.722 . . . . 73.120000000000005 112.47 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 49.93 29.45 14.0 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.745 -0.741 . . . . 75.349999999999994 112.459 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.691 ' HB3' ' HB3' ' A' ' 2' ' ' LYS . . . -107.99 129.69 55.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.747 0.308 . . . . 74.129999999999995 111.116 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -59.58 132.62 54.55 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.261 -0.427 . . . . 74.329999999999998 110.925 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -128.48 -73.04 0.59 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 75.420000000000002 110.869 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 78.33 -83.16 1.22 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.744 -0.741 . . . . 74.209999999999994 112.454 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -53.68 -34.56 59.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.845 0.355 . . . . 71.439999999999998 110.897 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -113.16 85.67 8.54 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.654 0.74 . . . . 64.049999999999997 110.85 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.82 -8.08 22.7 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.731 2.287 . . . . 65.120000000000005 112.33 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 25.6 p80 -133.02 21.51 4.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 72.209999999999994 110.875 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -99.35 86.33 0.7 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.743 -0.741 . . . . 74.450000000000003 112.555 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 52.6 m -141.9 154.8 45.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.841 0.353 . . . . 73.430000000000007 110.932 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -72.99 -22.39 60.69 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.171 -0.468 . . . . 74.540000000000006 110.875 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -121.27 -159.51 10.74 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.806 -0.711 . . . . 64.230000000000004 112.496 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -89.3 48.58 1.63 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.873 0.368 . . . . 74.150000000000006 110.861 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.466 ' HA ' ' HA3' ' A' ' 28' ' ' GLY . 6.5 m -110.54 149.83 29.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 62.25 110.858 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -127.71 156.9 20.79 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.693 -0.765 . . . . 52.25 112.49 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 22.4 m -88.88 57.94 4.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.875 0.369 . . . . 74.329999999999998 110.893 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.548 ' HG ' HG22 ' A' ' 23' ' ' VAL . 2.5 pt? -48.09 -33.97 8.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.194 -0.457 . . . . 74.430000000000007 110.922 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.622 HG23 ' CD2' ' A' ' 25' ' ' PHE . 1.8 m -133.3 9.63 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.471 . . . . 75.340000000000003 111.053 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 116.01 -7.52 19.19 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.679 -0.772 . . . . 53.119999999999997 112.449 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.622 ' CD2' HG23 ' A' ' 23' ' ' VAL . 1.3 m-85 -119.6 136.08 54.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.919 0.39 . . . . 74.329999999999998 110.877 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 11.9 m -63.26 102.37 0.39 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.137 -0.483 . . . . 73.430000000000007 110.905 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.546 ' HD2' HD22 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -118.75 115.07 23.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 74.299999999999997 110.892 -179.801 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.466 ' HA3' ' HA ' ' A' ' 19' ' ' CYS . . . -154.22 -140.02 2.95 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.767 -0.73 . . . . 61.240000000000002 112.522 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 4.0 m -150.82 36.89 0.63 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.796 0.331 . . . . 54.32 111.099 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -146.66 -38.06 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.696 -0.764 . . . . 62.020000000000003 112.436 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 33.3 m . . . . . 0 C--N 1.328 -0.335 0 CA-C-O 120.786 0.327 . . . . 74.530000000000001 110.856 -179.863 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 2.6 p . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.937 0.399 . . . . 44.43 110.845 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.48 -167.96 0.05 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.158 -0.474 . . . . 74.129999999999995 110.896 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -129.01 18.84 6.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.231 -0.441 . . . . 54.049999999999997 110.869 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 86.1 157.0 28.77 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.726 -0.75 . . . . 73.400000000000006 112.52 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 51.96 26.73 19.64 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.81 -0.709 . . . . 73.099999999999994 112.503 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -114.79 155.87 25.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.8 0.334 . . . . 75.219999999999999 111.111 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -74.48 131.08 40.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.155 -0.475 . . . . 64.019999999999996 110.905 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -128.23 -75.95 0.56 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.258 -0.428 . . . . 71.409999999999997 110.967 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 85.08 -64.71 4.18 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.705 -0.76 . . . . 33.229999999999997 112.492 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 55.7 p90 -61.65 -39.27 90.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.932 0.396 . . . . 75.340000000000003 110.873 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -114.43 76.52 3.85 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.595 0.712 . . . . 42.420000000000002 110.839 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.74 -5.37 16.04 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.7 2.267 . . . . 73.030000000000001 112.372 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 11.3 p80 -144.9 23.26 1.56 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 74.150000000000006 110.9 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -101.65 -92.34 2.17 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.72 -0.752 . . . . 44.409999999999997 112.451 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 50.29 -171.2 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.878 0.371 . . . . 65.519999999999996 110.881 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -78.27 -62.26 1.74 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 63.340000000000003 110.858 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.66 -153.16 27.66 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.744 -0.741 . . . . 55.299999999999997 112.51 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -89.03 46.36 1.38 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.933 0.396 . . . . 75.319999999999993 110.875 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.419 ' HA ' ' HA3' ' A' ' 28' ' ' GLY . 34.0 m -107.38 134.95 49.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.125 -0.489 . . . . 72.340000000000003 110.835 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -117.57 154.26 16.77 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.699 -0.762 . . . . 71.209999999999994 112.482 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 5.4 m -88.13 67.4 8.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.89 0.376 . . . . 71.120000000000005 110.939 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -50.54 -27.99 7.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.469 . . . . 60.399999999999999 110.918 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.466 ' O ' HG22 ' A' ' 23' ' ' VAL . 9.5 p -148.01 28.28 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 73.549999999999997 111.151 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 109.9 -36.34 4.35 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.767 -0.73 . . . . 62.020000000000003 112.46 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -97.52 129.18 44.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.951 0.405 . . . . 61.340000000000003 110.825 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 2.7 m -62.65 130.32 44.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.47 . . . . 70.340000000000003 110.867 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.44 ' O ' ' CG ' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -142.84 117.88 10.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.129 -0.487 . . . . 70.400000000000006 110.975 -179.882 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.419 ' HA3' ' HA ' ' A' ' 19' ' ' CYS . . . -153.9 -132.26 1.66 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.729 -0.748 . . . . 33.030000000000001 112.503 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.0 m -150.36 29.27 0.71 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.84 0.352 . . . . 75.040000000000006 111.153 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.548 ' O ' ' OXT' ' A' ' 31' ' ' CYS . . . -138.11 -56.93 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.743 -0.741 . . . . 61.009999999999998 112.497 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.548 ' OXT' ' O ' ' A' ' 30' ' ' GLY . 29.9 p . . . . . 0 C--N 1.329 -0.291 0 CA-C-O 120.785 0.326 . . . . 62.140000000000001 110.846 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 2.6 p . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.829 0.347 . . . . 72.409999999999997 110.892 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.18 -168.8 0.68 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.192 -0.458 . . . . 73.010000000000005 110.878 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.466 ' O ' ' OXT' ' A' ' 31' ' ' CYS . 0.5 OUTLIER -130.64 18.73 5.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.45 . . . . 71.0 110.855 -179.887 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 95.44 155.92 31.49 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.667 -0.777 . . . . 42.530000000000001 112.478 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 51.64 27.49 19.18 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.825 -0.703 . . . . 51.329999999999998 112.423 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -113.29 149.61 33.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.792 0.33 . . . . 52.210000000000001 111.097 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -70.59 131.38 43.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.174 -0.466 . . . . 74.219999999999999 110.949 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -129.19 -76.11 0.55 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.228 -0.442 . . . . 75.209999999999994 110.85 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 85.98 -69.77 3.13 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.761 -0.733 . . . . 51.399999999999999 112.432 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -59.63 -39.43 84.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.795 0.331 . . . . 71.310000000000002 110.867 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -112.73 76.89 2.27 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.61 0.719 . . . . 74.319999999999993 110.83 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.68 -5.55 16.42 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.668 2.246 . . . . 70.319999999999993 112.36 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 11.6 p80 -144.45 23.57 1.62 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.259 -0.428 . . . . 61.420000000000002 110.808 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -99.65 -92.86 2.07 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.721 -0.752 . . . . 74.439999999999998 112.496 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 49.99 -170.16 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.936 0.398 . . . . 71.439999999999998 110.824 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -83.93 -59.87 2.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 52.25 110.912 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.79 -155.36 30.74 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.779 -0.724 . . . . 65.349999999999994 112.447 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.1 p-10 -89.4 43.41 1.14 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.9 0.381 . . . . 61.350000000000001 110.947 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 5.4 m -107.13 121.76 45.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 55.210000000000001 110.879 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -103.55 155.81 17.84 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.742 -0.742 . . . . 62.43 112.458 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 5.0 m -88.32 71.13 9.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.857 0.36 . . . . 74.310000000000002 110.886 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.411 HD23 ' CD2' ' A' ' 27' ' ' TYR . 1.5 pp -47.49 -32.94 5.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.212 -0.449 . . . . 62.43 110.919 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.469 ' O ' HG22 ' A' ' 23' ' ' VAL . 9.9 p -147.29 30.83 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.2 -0.455 . . . . 71.230000000000004 111.163 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 109.66 -31.07 7.85 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.691 -0.766 . . . . 73.010000000000005 112.516 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -101.05 124.23 46.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.965 0.412 . . . . 73.310000000000002 110.852 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 6.8 m -61.33 131.41 50.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.112 -0.495 . . . . 73.400000000000006 110.875 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.465 ' O ' ' CG ' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -142.44 117.03 9.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 73.150000000000006 110.864 -179.894 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -154.09 -133.21 1.77 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.688 -0.768 . . . . 52.399999999999999 112.469 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.3 m -151.17 30.87 0.61 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.853 0.359 . . . . 65.209999999999994 111.158 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -150.39 15.21 0.97 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.775 -0.726 . . . . 21.109999999999999 112.481 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.466 ' OXT' ' O ' ' A' ' 3' ' ' SER . 4.8 m . . . . . 0 C--N 1.328 -0.33 0 CA-C-O 120.775 0.321 . . . . 74.430000000000007 110.905 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 17.6 p . . . . . 0 C--O 1.232 0.179 0 CA-C-O 120.886 0.374 . . . . 73.409999999999997 110.933 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.46 166.66 18.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.282 -0.417 . . . . 71.049999999999997 110.879 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -118.5 19.61 13.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 71.230000000000004 110.827 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 96.9 149.46 25.57 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.751 -0.738 . . . . 70.109999999999999 112.431 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 50.67 26.82 11.1 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.728 -0.749 . . . . 70.209999999999994 112.525 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -106.29 130.09 54.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.764 0.316 . . . . 74.400000000000006 111.1 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -58.52 134.21 56.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 61.219999999999999 110.958 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -126.88 -81.11 0.61 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.265 -0.425 . . . . 73.239999999999995 110.888 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 76.16 -62.61 2.96 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.758 -0.734 . . . . 42.210000000000001 112.481 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -50.43 -34.13 23.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.876 0.369 . . . . 73.129999999999995 110.903 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -146.08 115.87 4.73 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.628 0.728 . . . . 73.099999999999994 110.865 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 -8.01 22.51 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.665 2.243 . . . . 70.010000000000005 112.398 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -128.17 21.28 6.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.21 -0.45 . . . . 72.109999999999999 110.821 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -88.32 65.67 3.36 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.705 -0.759 . . . . 53.210000000000001 112.48 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 12.9 m -138.76 156.9 46.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.82 0.343 . . . . 75.129999999999995 110.94 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -53.5 -61.89 2.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 44.409999999999997 110.883 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.51 -152.26 26.06 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.755 -0.736 . . . . 74.439999999999998 112.517 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.5 p-10 -88.79 46.23 1.37 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.854 0.359 . . . . 62.219999999999999 110.874 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.41 ' HA ' ' HA3' ' A' ' 28' ' ' GLY . 62.5 m -91.2 129.69 37.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.229 -0.441 . . . . 74.329999999999998 110.88 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -112.54 150.29 18.31 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.749 -0.738 . . . . 52.539999999999999 112.457 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 38.2 m -89.21 65.2 7.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.903 0.383 . . . . 54.210000000000001 110.87 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.897 ' HG ' HG23 ' A' ' 23' ' ' VAL . 2.6 pt? -44.77 -36.21 3.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.475 . . . . 74.420000000000002 110.918 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.897 HG23 ' HG ' ' A' ' 22' ' ' LEU . 25.8 t -134.91 8.23 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.465 . . . . 70.510000000000005 111.183 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 117.62 5.19 14.42 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.811 -0.709 . . . . 51.539999999999999 112.509 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -128.39 130.5 47.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.835 0.35 . . . . 73.409999999999997 110.903 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 56.1 m -51.57 124.46 12.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.156 -0.475 . . . . 64.510000000000005 110.84 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.433 ' CD2' HD22 ' A' ' 22' ' ' LEU . 0.3 OUTLIER -150.52 111.17 4.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 74.329999999999998 110.928 -179.937 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.41 ' HA3' ' HA ' ' A' ' 19' ' ' CYS . . . -153.78 -127.12 1.15 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.747 -0.739 . . . . 62.43 112.488 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.0 m -150.36 31.08 0.67 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.829 0.347 . . . . 75.519999999999996 111.16 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -138.48 -55.07 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.676 -0.773 . . . . 73.329999999999998 112.491 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.665 ' OXT' ' SG ' ' A' ' 31' ' ' CYS . 14.0 p . . . . . 0 C--N 1.33 -0.246 0 CA-C-O 120.806 0.336 . . . . 70.209999999999994 110.86 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 1.8 p . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.934 0.397 . . . . 64.109999999999999 110.869 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.9 mmpt? -76.15 -168.2 0.89 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.137 -0.483 . . . . 72.010000000000005 110.894 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.2 m -121.67 13.19 10.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.235 -0.439 . . . . 75.329999999999998 110.875 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 92.29 154.33 30.83 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.706 -0.759 . . . . 74.129999999999995 112.495 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 49.84 46.52 40.02 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.76 -0.733 . . . . 70.420000000000002 112.448 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -135.28 148.22 49.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.776 0.322 . . . . 43.039999999999999 111.116 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -64.12 128.79 37.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.16 -0.473 . . . . 73.400000000000006 110.945 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.7 p -117.48 -54.24 2.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.445 . . . . 63.340000000000003 110.876 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 70.57 -81.73 0.39 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.697 -0.763 . . . . 71.549999999999997 112.525 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -60.6 -37.18 80.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.873 0.368 . . . . 73.030000000000001 110.853 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -112.53 75.47 1.8 Allowed Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.608 0.718 . . . . 73.010000000000005 110.885 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.8 -5.84 17.2 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.678 2.252 . . . . 72.400000000000006 112.348 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -142.18 21.75 2.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.224 -0.444 . . . . 70.129999999999995 110.891 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -87.57 -95.07 0.94 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.723 -0.751 . . . . 30.010000000000002 112.453 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 51.07 -171.77 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.886 0.374 . . . . 72.329999999999998 110.84 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -89.14 -57.98 2.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.166 -0.47 . . . . 73.129999999999995 110.927 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.76 -157.08 32.79 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.765 -0.731 . . . . 75.439999999999998 112.478 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -88.44 49.32 1.77 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.841 0.353 . . . . 52.399999999999999 110.863 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.466 ' HA ' ' HA3' ' A' ' 28' ' ' GLY . 86.2 m -102.33 123.5 46.24 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.156 -0.475 . . . . 71.5 110.937 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -100.01 149.55 18.79 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.691 -0.766 . . . . 72.540000000000006 112.57 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 69.3 m -89.11 68.63 8.26 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.807 0.337 . . . . 73.200000000000003 110.862 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.61 ' HG ' HG22 ' A' ' 23' ' ' VAL . 2.5 pt? -49.29 -31.73 9.59 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.258 -0.428 . . . . 71.209999999999994 110.854 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.61 HG22 ' HG ' ' A' ' 22' ' ' LEU . 3.3 m -142.18 23.48 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.126 -0.488 . . . . 70.129999999999995 111.149 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 109.94 -29.45 9.3 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.753 -0.737 . . . . 75.230000000000004 112.506 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.49 ' CD2' HG23 ' A' ' 23' ' ' VAL . 0.6 OUTLIER -98.77 130.88 45.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.959 0.409 . . . . 72.230000000000004 110.854 -179.868 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 87.1 m -57.68 126.91 29.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 64.299999999999997 110.871 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.486 ' HD2' HD22 ' A' ' 22' ' ' LEU . 0.1 OUTLIER -151.26 111.19 4.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.169 -0.469 . . . . 55.439999999999998 110.856 -179.909 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.466 ' HA3' ' HA ' ' A' ' 19' ' ' CYS . . . -154.81 -123.91 0.88 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.699 -0.762 . . . . 63.340000000000003 112.484 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.0 m -150.8 29.25 0.68 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.83 0.348 . . . . 75.299999999999997 111.11 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -129.54 -65.47 0.11 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.721 -0.752 . . . . 60.229999999999997 112.461 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 21.0 p . . . . . 0 C--N 1.328 -0.355 0 CA-C-O 120.796 0.331 . . . . 52.329999999999998 110.891 -179.872 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 29.5 p . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.896 0.379 . . . . 24.14 110.883 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.518 ' HB3' ' HB3' ' A' ' 6' ' ' ALA . 0.0 OUTLIER -65.58 143.75 57.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.205 -0.452 . . . . 54.32 110.903 179.924 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -94.47 21.75 6.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.201 -0.454 . . . . 65.41 110.908 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 92.65 151.66 28.0 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.75 -0.738 . . . . 74.22 112.489 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 50.89 27.73 14.46 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.701 -0.762 . . . . 63.51 112.538 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.518 ' HB3' ' HB3' ' A' ' 2' ' ' LYS . . . -108.44 149.36 28.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.803 0.335 . . . . 63.52 111.135 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -75.32 135.34 40.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 72.21 110.914 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -131.2 -69.14 0.64 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.245 -0.434 . . . . 71.21 110.903 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 73.42 -85.79 0.61 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.712 -0.756 . . . . 61.05 112.52 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -51.32 -34.82 35.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.802 0.334 . . . . 71.34 110.851 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -111.73 82.4 3.89 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.541 0.686 . . . . 62.31 110.83 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.87 -7.44 21.08 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.686 2.257 . . . . 65.2 112.358 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 37.2 m-70 -130.82 21.4 5.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.456 . . . . 71.53 110.867 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -101.31 85.94 0.59 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.75 -0.738 . . . . 74.55 112.513 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 61.6 m -143.48 145.76 32.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.843 0.354 . . . . 63.44 110.964 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -56.84 -55.58 32.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 73.3 110.843 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.32 -159.74 35.72 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.761 -0.733 . . . . 52.12 112.458 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -88.46 50.97 2.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.865 0.364 . . . . 74.43 110.938 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.421 ' HA ' ' HA3' ' A' ' 28' ' ' GLY . 14.3 m -113.76 151.3 32.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.233 -0.44 . . . . 71.22 110.815 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -129.91 162.44 22.97 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.725 -0.75 . . . . 73.23 112.484 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 14.6 m -89.18 61.41 5.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.871 0.367 . . . . 65.35 110.868 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.533 HD22 ' HD2' ' A' ' 27' ' ' TYR . 2.5 pt? -49.77 -29.99 8.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 65.11 110.856 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.446 HG22 ' O ' ' A' ' 23' ' ' VAL . 7.0 p -142.83 20.45 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 64.24 111.111 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 108.34 -13.34 36.55 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.668 -0.777 . . . . 34.44 112.562 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -115.95 135.66 53.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.827 0.346 . . . . 75.33 110.911 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 17.5 m -64.35 109.6 1.97 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.189 -0.46 . . . . 65.24 110.874 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.533 ' HD2' HD22 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -128.76 117.59 21.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.191 -0.459 . . . . 71.32 110.979 -179.922 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.421 ' HA3' ' HA ' ' A' ' 19' ' ' CYS . . . -153.33 -132.84 1.78 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.711 -0.757 . . . . 45.32 112.504 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.9 m -150.33 29.72 0.7 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.787 0.327 . . . . 62.44 111.153 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -141.09 -55.28 0.04 OUTLIER Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.653 -0.784 . . . . 70.51 112.441 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 27.6 p . . . . . 0 C--N 1.328 -0.337 0 CA-C-O 120.765 0.316 . . . . 51.32 110.862 -179.834 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 29.0 p . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.947 0.403 . . . . 52.23 110.898 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.607 ' HB3' ' HB3' ' A' ' 6' ' ' ALA . 0.0 OUTLIER -68.55 125.89 27.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.15 -0.477 . . . . 73.13 110.828 179.978 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.73 -12.42 61.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 75.12 110.931 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 131.69 152.13 7.09 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.712 -0.756 . . . . 72.11 112.455 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 51.6 26.18 15.65 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.741 -0.743 . . . . 75.2 112.473 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.607 ' HB3' ' HB3' ' A' ' 2' ' ' LYS . . . -103.44 151.54 22.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.753 0.311 . . . . 71.22 111.104 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -77.85 136.22 38.04 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.257 -0.429 . . . . 74.22 110.868 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -131.19 -70.45 0.6 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.221 -0.445 . . . . 53.43 110.878 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 75.08 -85.17 0.8 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.65 -0.786 . . . . 61.44 112.505 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -51.88 -35.97 46.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.855 0.36 . . . . 74.31 110.856 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -110.58 82.14 2.73 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.621 0.724 . . . . 64.51 110.897 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -8.56 23.93 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.729 2.286 . . . . 74.41 112.377 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 6.1 m170 -128.24 19.3 6.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.246 -0.434 . . . . 71.22 110.87 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -100.47 88.36 0.76 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.818 -0.706 . . . . 65.51 112.519 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 65.6 m -144.76 143.83 30.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.866 0.365 . . . . 70.03 110.867 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -54.61 -56.76 15.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 63.12 110.927 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.32 -158.6 34.44 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.731 -0.747 . . . . 62.11 112.567 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -88.69 50.77 2.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.85 0.357 . . . . 73.14 110.878 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.411 ' HA ' ' HA3' ' A' ' 28' ' ' GLY . 14.2 m -113.5 153.75 28.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.166 -0.47 . . . . 62.13 110.831 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -132.25 162.51 23.98 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.7 -0.762 . . . . 71.51 112.471 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 14.2 m -88.97 61.3 5.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.888 0.375 . . . . 74.41 110.896 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.519 HD22 ' HD2' ' A' ' 27' ' ' TYR . 2.6 pt? -49.67 -30.14 8.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.231 -0.441 . . . . 53.21 110.919 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.435 HG22 ' O ' ' A' ' 23' ' ' VAL . 6.9 p -143.92 22.8 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.114 -0.494 . . . . 72.02 111.109 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 107.11 -15.05 40.08 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.732 -0.747 . . . . 51.1 112.481 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -114.98 135.75 53.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.885 0.374 . . . . 73.32 110.851 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 15.7 m -65.14 111.0 2.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 71.14 110.902 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.519 ' HD2' HD22 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -129.28 117.88 21.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.115 -0.493 . . . . 74.14 110.896 -179.881 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.411 ' HA3' ' HA ' ' A' ' 19' ' ' CYS . . . -153.45 -132.6 1.74 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.771 -0.728 . . . . 73.01 112.516 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.9 m -150.38 29.55 0.7 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.862 0.363 . . . . 73.42 111.116 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -141.01 -55.03 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.791 -0.719 . . . . 44.2 112.547 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 26.9 p . . . . . 0 C--N 1.328 -0.358 0 CA-C-O 120.775 0.322 . . . . 71.14 110.885 -179.916 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 5.1 p . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.914 0.388 . . . . 75.31 110.905 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.8 -169.03 0.11 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 74.41 110.901 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -128.6 20.83 6.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.45 . . . . 72.02 110.851 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 88.82 152.5 25.56 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.755 -0.736 . . . . 60.03 112.552 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 51.78 25.49 15.51 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.738 -0.744 . . . . 61.0 112.464 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -107.85 157.23 18.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.778 0.323 . . . . 63.22 111.119 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -76.71 133.63 39.45 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.197 -0.456 . . . . 71.33 110.849 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -130.19 -74.14 0.55 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.24 -0.436 . . . . 64.11 110.875 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.5 -78.27 1.95 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.748 -0.739 . . . . 54.52 112.427 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -56.65 -34.75 67.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.874 0.368 . . . . 72.32 110.917 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -112.4 77.22 2.19 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.591 0.71 . . . . 71.22 110.865 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 -6.4 18.54 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.668 2.246 . . . . 63.32 112.327 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 9.7 p80 -138.06 24.17 2.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.445 . . . . 61.43 110.835 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -121.96 114.44 2.52 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.772 -0.728 . . . . 61.11 112.493 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -160.92 178.47 9.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.853 0.359 . . . . 70.0 110.872 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -72.4 -22.99 61.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.191 -0.459 . . . . 50.03 110.808 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -130.52 -162.17 10.61 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.748 -0.739 . . . . 71.24 112.436 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -88.67 48.51 1.64 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.892 0.377 . . . . 64.33 110.92 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.412 ' HA ' ' HA3' ' A' ' 28' ' ' GLY . 7.9 m -113.09 127.43 56.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.169 -0.469 . . . . 65.21 110.879 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -104.57 157.17 16.93 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.8 -0.714 . . . . 70.2 112.499 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 13.2 m -87.3 65.17 8.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.825 0.345 . . . . 63.01 110.843 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.466 HD22 ' HD2' ' A' ' 27' ' ' TYR . 2.6 pt? -50.2 -30.41 11.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.117 -0.492 . . . . 64.42 110.848 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.444 HG22 ' O ' ' A' ' 23' ' ' VAL . 7.5 p -145.0 24.88 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.248 -0.433 . . . . 51.12 111.142 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 109.17 -23.84 22.21 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.727 -0.749 . . . . 53.2 112.479 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -106.15 130.5 54.03 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.918 0.389 . . . . 73.01 110.835 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 1.2 m -65.37 106.93 1.49 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 52.42 110.904 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.466 ' HD2' HD22 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -121.93 118.93 30.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.156 -0.474 . . . . 73.43 110.954 -179.908 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.412 ' HA3' ' HA ' ' A' ' 19' ' ' CYS . . . -153.5 -133.21 1.81 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.667 -0.778 . . . . 70.32 112.47 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.2 m -150.28 31.24 0.68 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.864 0.364 . . . . 74.53 111.126 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.418 ' O ' ' OXT' ' A' ' 31' ' ' CYS . . . -139.62 -58.47 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.711 -0.757 . . . . 75.51 112.464 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.418 ' OXT' ' O ' ' A' ' 30' ' ' GLY . 31.3 p . . . . . 0 C--N 1.328 -0.348 0 CA-C-O 120.79 0.329 . . . . 54.41 110.86 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 5.7 p . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.956 0.408 . . . . 63.33 110.887 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.62 ' HB3' ' HB3' ' A' ' 6' ' ' ALA . 0.0 OUTLIER -72.07 128.45 35.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 60.01 110.896 179.961 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -94.41 25.82 3.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 74.43 110.869 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 100.15 149.45 23.77 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.723 -0.751 . . . . 14.21 112.476 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 49.76 34.59 21.95 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.796 -0.716 . . . . 61.25 112.433 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.62 ' HB3' ' HB3' ' A' ' 2' ' ' LYS . . . -108.97 143.55 38.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.83 0.347 . . . . 70.13 111.073 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -72.59 132.32 43.61 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.181 -0.463 . . . . 75.22 110.999 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -131.35 -69.95 0.61 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.441 . . . . 60.11 110.825 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 75.14 -85.11 0.81 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.776 -0.726 . . . . 63.21 112.443 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -52.52 -36.86 56.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.901 0.382 . . . . 65.43 110.922 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -109.98 85.64 4.32 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.614 0.721 . . . . 73.14 110.88 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.83 -5.86 17.26 Favored 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.639 2.226 . . . . 64.31 112.279 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 26.0 m-70 -136.75 23.17 3.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.302 -0.408 . . . . 75.11 110.85 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -102.67 86.33 0.55 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.778 -0.725 . . . . 74.33 112.531 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 38.2 m -141.38 162.67 34.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.848 0.356 . . . . 53.23 110.934 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -60.15 -45.72 92.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.168 -0.469 . . . . 75.2 110.873 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -111.11 -146.24 10.52 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.748 -0.739 . . . . 72.04 112.487 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -88.9 41.08 1.01 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.907 0.384 . . . . 65.41 110.905 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.411 ' HA ' ' HA3' ' A' ' 28' ' ' GLY . 67.8 m -89.48 142.22 27.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 75.14 110.855 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -126.01 148.85 17.19 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.74 -0.743 . . . . 63.4 112.498 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 14.1 m -88.73 63.74 7.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.846 0.355 . . . . 70.45 110.862 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -49.64 -27.98 5.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.187 -0.461 . . . . 74.12 110.912 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.433 HG22 ' O ' ' A' ' 23' ' ' VAL . 7.1 p -145.31 18.88 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 72.04 111.162 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 109.65 -10.26 32.62 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.733 -0.746 . . . . 74.51 112.508 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -115.09 129.45 56.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.906 0.384 . . . . 74.32 110.879 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 5.8 m -59.18 127.91 34.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.151 -0.477 . . . . 74.51 110.838 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -150.05 116.87 5.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 75.02 110.989 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.411 ' HA3' ' HA ' ' A' ' 19' ' ' CYS . . . -154.28 -133.98 1.87 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.754 -0.736 . . . . 53.24 112.482 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.406 HG22 ' O ' ' A' ' 29' ' ' THR . 3.8 m -150.9 32.79 0.6 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.857 0.36 . . . . 65.31 111.124 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -150.4 15.79 0.98 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.768 -0.729 . . . . 62.2 112.502 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 5.6 m . . . . . 0 C--N 1.329 -0.311 0 CA-C-O 120.801 0.334 . . . . 73.32 110.907 -179.965 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 2.5 p . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.904 0.383 . . . . 62.24 110.906 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -72.05 -168.66 0.41 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 71.32 110.886 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -126.78 17.03 7.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 44.03 110.852 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 87.56 157.08 30.94 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.806 -0.711 . . . . 73.34 112.488 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 51.83 27.33 20.26 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.718 -0.753 . . . . 74.43 112.525 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -115.96 155.37 28.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.735 0.302 . . . . 74.41 111.14 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -74.18 131.38 41.2 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.215 -0.448 . . . . 72.43 110.891 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -129.5 -76.23 0.55 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.234 -0.439 . . . . 43.03 110.902 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 84.15 -60.58 4.82 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.713 -0.756 . . . . 64.33 112.515 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 56.1 p90 -63.21 -38.95 93.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.882 0.373 . . . . 71.35 110.872 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -116.03 76.14 6.2 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.582 0.706 . . . . 72.13 110.865 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.75 -5.4 16.12 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.65 2.233 . . . . 72.31 112.323 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -144.33 24.14 1.61 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 60.15 110.838 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -105.18 -91.3 2.22 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.697 -0.763 . . . . 30.55 112.474 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 49.93 -170.45 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.92 0.39 . . . . 54.53 110.853 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -81.52 -59.16 2.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.475 . . . . 70.52 110.897 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.73 -156.55 32.13 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.773 -0.727 . . . . 73.33 112.522 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 11.2 p-10 -88.96 47.8 1.55 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.834 0.349 . . . . 74.52 110.878 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.413 ' HA ' ' HA3' ' A' ' 28' ' ' GLY . 9.5 m -112.64 138.74 48.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.182 -0.463 . . . . 71.45 110.87 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -118.8 156.35 15.7 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.728 -0.749 . . . . 71.11 112.518 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 5.7 m -87.98 65.98 8.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.892 0.377 . . . . 53.12 110.913 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -49.67 -31.41 10.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.124 -0.489 . . . . 71.43 110.909 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.471 HG22 ' O ' ' A' ' 23' ' ' VAL . 9.8 p -144.89 28.85 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 64.22 111.076 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 110.2 -38.59 3.24 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.83 -0.7 . . . . 54.25 112.445 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -96.1 131.27 42.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.862 0.363 . . . . 75.0 110.886 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 1.7 m -64.46 126.15 26.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.248 -0.433 . . . . 74.32 110.87 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.426 ' O ' ' CG ' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -137.42 118.53 14.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 71.55 110.943 -179.931 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.413 ' HA3' ' HA ' ' A' ' 19' ' ' CYS . . . -153.98 -134.33 1.94 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.758 -0.734 . . . . 63.32 112.51 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.1 m -150.14 30.67 0.7 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.782 0.325 . . . . 64.12 111.179 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -140.38 -55.4 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.782 -0.723 . . . . 64.31 112.526 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 27.1 p . . . . . 0 C--N 1.328 -0.337 0 CA-C-O 120.817 0.342 . . . . 64.25 110.829 -179.866 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 5.2 p . . . . . 0 C--O 1.232 0.18 0 CA-C-O 120.921 0.391 . . . . 72.55 110.835 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.691 ' HB3' ' HB3' ' A' ' 6' ' ' ALA . 0.0 OUTLIER -73.77 142.24 46.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 73.23 110.82 179.922 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -98.73 20.43 13.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.173 -0.467 . . . . 72.25 110.876 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 101.82 150.03 22.99 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.783 -0.722 . . . . 73.12 112.47 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 49.93 29.45 14.0 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.745 -0.741 . . . . 75.35 112.459 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.691 ' HB3' ' HB3' ' A' ' 2' ' ' LYS . . . -107.99 129.69 55.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.747 0.308 . . . . 74.13 111.116 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -59.58 132.62 54.55 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.261 -0.427 . . . . 74.33 110.925 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -128.48 -73.04 0.59 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 75.42 110.869 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 78.33 -83.16 1.22 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.744 -0.741 . . . . 74.21 112.454 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -53.68 -34.56 59.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.845 0.355 . . . . 71.44 110.897 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -113.16 85.67 8.54 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.654 0.74 . . . . 64.05 110.85 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.82 -8.08 22.7 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.731 2.287 . . . . 65.12 112.33 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 25.6 p80 -133.02 21.51 4.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 72.21 110.875 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -99.35 86.33 0.7 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.743 -0.741 . . . . 74.45 112.555 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 52.6 m -141.9 154.8 45.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.841 0.353 . . . . 73.43 110.932 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -72.99 -22.39 60.69 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.171 -0.468 . . . . 74.54 110.875 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -121.27 -159.51 10.74 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.806 -0.711 . . . . 64.23 112.496 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -89.3 48.58 1.63 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.873 0.368 . . . . 74.15 110.861 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.466 ' HA ' ' HA3' ' A' ' 28' ' ' GLY . 6.5 m -110.54 149.83 29.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 62.25 110.858 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -127.71 156.9 20.79 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.693 -0.765 . . . . 52.25 112.49 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 22.4 m -88.88 57.94 4.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.875 0.369 . . . . 74.33 110.893 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.548 ' HG ' HG22 ' A' ' 23' ' ' VAL . 2.5 pt? -48.09 -33.97 8.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.194 -0.457 . . . . 74.43 110.922 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.622 HG23 ' CD2' ' A' ' 25' ' ' PHE . 1.8 m -133.3 9.63 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.471 . . . . 75.34 111.053 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 116.01 -7.52 19.19 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.679 -0.772 . . . . 53.12 112.449 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.622 ' CD2' HG23 ' A' ' 23' ' ' VAL . 1.3 m-85 -119.6 136.08 54.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.919 0.39 . . . . 74.33 110.877 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 11.9 m -63.26 102.37 0.39 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.137 -0.483 . . . . 73.43 110.905 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.546 ' HD2' HD22 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -118.75 115.07 23.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 74.3 110.892 -179.801 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.466 ' HA3' ' HA ' ' A' ' 19' ' ' CYS . . . -154.22 -140.02 2.95 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.767 -0.73 . . . . 61.24 112.522 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 4.0 m -150.82 36.89 0.63 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.796 0.331 . . . . 54.32 111.099 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -146.66 -38.06 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.696 -0.764 . . . . 62.02 112.436 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 33.3 m . . . . . 0 C--N 1.328 -0.335 0 CA-C-O 120.786 0.327 . . . . 74.53 110.856 -179.863 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 2.6 p . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.937 0.399 . . . . 44.43 110.845 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.48 -167.96 0.05 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.158 -0.474 . . . . 74.13 110.896 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -129.01 18.84 6.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.231 -0.441 . . . . 54.05 110.869 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 86.1 157.0 28.77 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.726 -0.75 . . . . 73.4 112.52 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 51.96 26.73 19.64 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.81 -0.709 . . . . 73.1 112.503 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -114.79 155.87 25.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.8 0.334 . . . . 75.22 111.111 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -74.48 131.08 40.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.155 -0.475 . . . . 64.02 110.905 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -128.23 -75.95 0.56 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.258 -0.428 . . . . 71.41 110.967 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 85.08 -64.71 4.18 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.705 -0.76 . . . . 33.23 112.492 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 55.7 p90 -61.65 -39.27 90.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.932 0.396 . . . . 75.34 110.873 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -114.43 76.52 3.85 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.595 0.712 . . . . 42.42 110.839 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.74 -5.37 16.04 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.7 2.267 . . . . 73.03 112.372 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 11.3 p80 -144.9 23.26 1.56 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 74.15 110.9 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -101.65 -92.34 2.17 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.72 -0.752 . . . . 44.41 112.451 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 50.29 -171.2 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.878 0.371 . . . . 65.52 110.881 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -78.27 -62.26 1.74 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 63.34 110.858 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.66 -153.16 27.66 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.744 -0.741 . . . . 55.3 112.51 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -89.03 46.36 1.38 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.933 0.396 . . . . 75.32 110.875 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.419 ' HA ' ' HA3' ' A' ' 28' ' ' GLY . 34.0 m -107.38 134.95 49.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.125 -0.489 . . . . 72.34 110.835 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -117.57 154.26 16.77 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.699 -0.762 . . . . 71.21 112.482 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 5.4 m -88.13 67.4 8.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.89 0.376 . . . . 71.12 110.939 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -50.54 -27.99 7.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.469 . . . . 60.4 110.918 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.466 HG22 ' O ' ' A' ' 23' ' ' VAL . 9.5 p -148.01 28.28 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 73.55 111.151 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 109.9 -36.34 4.35 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.767 -0.73 . . . . 62.02 112.46 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -97.52 129.18 44.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.951 0.405 . . . . 61.34 110.825 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 2.7 m -62.65 130.32 44.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.47 . . . . 70.34 110.867 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.44 ' O ' ' CG ' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -142.84 117.88 10.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.129 -0.487 . . . . 70.4 110.975 -179.882 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.419 ' HA3' ' HA ' ' A' ' 19' ' ' CYS . . . -153.9 -132.26 1.66 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.729 -0.748 . . . . 33.03 112.503 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.0 m -150.36 29.27 0.71 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.84 0.352 . . . . 75.04 111.153 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.548 ' O ' ' OXT' ' A' ' 31' ' ' CYS . . . -138.11 -56.93 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.743 -0.741 . . . . 61.01 112.497 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.548 ' OXT' ' O ' ' A' ' 30' ' ' GLY . 29.9 p . . . . . 0 C--N 1.329 -0.291 0 CA-C-O 120.785 0.326 . . . . 62.14 110.846 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 2.6 p . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.829 0.347 . . . . 72.41 110.892 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.18 -168.8 0.68 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.192 -0.458 . . . . 73.01 110.878 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.466 ' O ' ' OXT' ' A' ' 31' ' ' CYS . 0.5 OUTLIER -130.64 18.73 5.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.45 . . . . 71.0 110.855 -179.887 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 95.44 155.92 31.49 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.667 -0.777 . . . . 42.53 112.478 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 51.64 27.49 19.18 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.825 -0.703 . . . . 51.33 112.423 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -113.29 149.61 33.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.792 0.33 . . . . 52.21 111.097 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -70.59 131.38 43.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.174 -0.466 . . . . 74.22 110.949 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -129.19 -76.11 0.55 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.228 -0.442 . . . . 75.21 110.85 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 85.98 -69.77 3.13 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.761 -0.733 . . . . 51.4 112.432 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -59.63 -39.43 84.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.795 0.331 . . . . 71.31 110.867 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -112.73 76.89 2.27 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.61 0.719 . . . . 74.32 110.83 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.68 -5.55 16.42 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.668 2.246 . . . . 70.32 112.36 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 11.6 p80 -144.45 23.57 1.62 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.259 -0.428 . . . . 61.42 110.808 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -99.65 -92.86 2.07 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.721 -0.752 . . . . 74.44 112.496 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 49.99 -170.16 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.936 0.398 . . . . 71.44 110.824 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -83.93 -59.87 2.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 52.25 110.912 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.79 -155.36 30.74 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.779 -0.724 . . . . 65.35 112.447 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -89.4 43.41 1.14 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.9 0.381 . . . . 61.35 110.947 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 5.4 m -107.13 121.76 45.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 55.21 110.879 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -103.55 155.81 17.84 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.742 -0.742 . . . . 62.43 112.458 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 5.0 m -88.32 71.13 9.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.857 0.36 . . . . 74.31 110.886 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.411 HD23 ' CD2' ' A' ' 27' ' ' TYR . 1.5 pp -47.49 -32.94 5.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.212 -0.449 . . . . 62.43 110.919 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.469 HG22 ' O ' ' A' ' 23' ' ' VAL . 9.9 p -147.29 30.83 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.2 -0.455 . . . . 71.23 111.163 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 109.66 -31.07 7.85 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.691 -0.766 . . . . 73.01 112.516 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -101.05 124.23 46.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.965 0.412 . . . . 73.31 110.852 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 6.8 m -61.33 131.41 50.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.112 -0.495 . . . . 73.4 110.875 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.465 ' O ' ' CG ' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -142.44 117.03 9.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 73.15 110.864 -179.894 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -154.09 -133.21 1.77 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.688 -0.768 . . . . 52.4 112.469 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.3 m -151.17 30.87 0.61 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.853 0.359 . . . . 65.21 111.158 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -150.39 15.21 0.97 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.775 -0.726 . . . . 21.11 112.481 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.466 ' OXT' ' O ' ' A' ' 3' ' ' SER . 4.8 m . . . . . 0 C--N 1.328 -0.33 0 CA-C-O 120.775 0.321 . . . . 74.43 110.905 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 17.6 p . . . . . 0 C--O 1.232 0.179 0 CA-C-O 120.886 0.374 . . . . 73.41 110.933 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.46 166.66 18.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.282 -0.417 . . . . 71.05 110.879 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -118.5 19.61 13.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 71.23 110.827 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 96.9 149.46 25.57 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.751 -0.738 . . . . 70.11 112.431 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 50.67 26.82 11.1 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.728 -0.749 . . . . 70.21 112.525 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -106.29 130.09 54.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.764 0.316 . . . . 74.4 111.1 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -58.52 134.21 56.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 61.22 110.958 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -126.88 -81.11 0.61 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.265 -0.425 . . . . 73.24 110.888 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 76.16 -62.61 2.96 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.758 -0.734 . . . . 42.21 112.481 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -50.43 -34.13 23.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.876 0.369 . . . . 73.13 110.903 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -146.08 115.87 4.73 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.628 0.728 . . . . 73.1 110.865 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 -8.01 22.51 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.665 2.243 . . . . 70.01 112.398 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -128.17 21.28 6.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.21 -0.45 . . . . 72.11 110.821 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -88.32 65.67 3.36 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.705 -0.759 . . . . 53.21 112.48 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 12.9 m -138.76 156.9 46.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.82 0.343 . . . . 75.13 110.94 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -53.5 -61.89 2.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 44.41 110.883 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.51 -152.26 26.06 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.755 -0.736 . . . . 74.44 112.517 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -88.79 46.23 1.37 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.854 0.359 . . . . 62.22 110.874 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.41 ' HA ' ' HA3' ' A' ' 28' ' ' GLY . 62.5 m -91.2 129.69 37.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.229 -0.441 . . . . 74.33 110.88 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -112.54 150.29 18.31 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.749 -0.738 . . . . 52.54 112.457 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 38.2 m -89.21 65.2 7.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.903 0.383 . . . . 54.21 110.87 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.897 ' HG ' HG23 ' A' ' 23' ' ' VAL . 2.6 pt? -44.77 -36.21 3.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.475 . . . . 74.42 110.918 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.897 HG23 ' HG ' ' A' ' 22' ' ' LEU . 25.8 t -134.91 8.23 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.465 . . . . 70.51 111.183 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 117.62 5.19 14.42 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.811 -0.709 . . . . 51.54 112.509 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -128.39 130.5 47.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.835 0.35 . . . . 73.41 110.903 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 56.1 m -51.57 124.46 12.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.156 -0.475 . . . . 64.51 110.84 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.433 ' CD2' HD22 ' A' ' 22' ' ' LEU . 0.3 OUTLIER -150.52 111.17 4.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 74.33 110.928 -179.937 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.41 ' HA3' ' HA ' ' A' ' 19' ' ' CYS . . . -153.78 -127.12 1.15 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.747 -0.739 . . . . 62.43 112.488 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.0 m -150.36 31.08 0.67 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.829 0.347 . . . . 75.52 111.16 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -138.48 -55.07 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.676 -0.773 . . . . 73.33 112.491 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.665 ' SG ' ' OXT' ' A' ' 31' ' ' CYS . 14.0 p . . . . . 0 C--N 1.33 -0.246 0 CA-C-O 120.806 0.336 . . . . 70.21 110.86 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 1.8 p . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.934 0.397 . . . . 64.11 110.869 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.9 mmpt? -76.15 -168.2 0.89 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.137 -0.483 . . . . 72.01 110.894 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.2 m -121.67 13.19 10.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.235 -0.439 . . . . 75.33 110.875 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 92.29 154.33 30.83 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.706 -0.759 . . . . 74.13 112.495 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 49.84 46.52 40.02 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.76 -0.733 . . . . 70.42 112.448 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -135.28 148.22 49.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.776 0.322 . . . . 43.04 111.116 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -64.12 128.79 37.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.16 -0.473 . . . . 73.4 110.945 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.7 p -117.48 -54.24 2.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.445 . . . . 63.34 110.876 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 70.57 -81.73 0.39 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.697 -0.763 . . . . 71.55 112.525 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -60.6 -37.18 80.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.873 0.368 . . . . 73.03 110.853 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -112.53 75.47 1.8 Allowed Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.608 0.718 . . . . 73.01 110.885 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.8 -5.84 17.2 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.678 2.252 . . . . 72.4 112.348 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -142.18 21.75 2.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.224 -0.444 . . . . 70.13 110.891 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -87.57 -95.07 0.94 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.723 -0.751 . . . . 30.01 112.453 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 51.07 -171.77 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.886 0.374 . . . . 72.33 110.84 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -89.14 -57.98 2.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.166 -0.47 . . . . 73.13 110.927 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.76 -157.08 32.79 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.765 -0.731 . . . . 75.44 112.478 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -88.44 49.32 1.77 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.841 0.353 . . . . 52.4 110.863 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.466 ' HA ' ' HA3' ' A' ' 28' ' ' GLY . 86.2 m -102.33 123.5 46.24 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.156 -0.475 . . . . 71.5 110.937 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -100.01 149.55 18.79 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.691 -0.766 . . . . 72.54 112.57 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 69.3 m -89.11 68.63 8.26 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.807 0.337 . . . . 73.2 110.862 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.61 ' HG ' HG22 ' A' ' 23' ' ' VAL . 2.5 pt? -49.29 -31.73 9.59 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.258 -0.428 . . . . 71.21 110.854 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.61 HG22 ' HG ' ' A' ' 22' ' ' LEU . 3.3 m -142.18 23.48 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.126 -0.488 . . . . 70.13 111.149 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 109.94 -29.45 9.3 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.753 -0.737 . . . . 75.23 112.506 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.49 ' CD2' HG23 ' A' ' 23' ' ' VAL . 0.6 OUTLIER -98.77 130.88 45.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.959 0.409 . . . . 72.23 110.854 -179.868 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 87.1 m -57.68 126.91 29.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 64.3 110.871 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.486 ' HD2' HD22 ' A' ' 22' ' ' LEU . 0.1 OUTLIER -151.26 111.19 4.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.169 -0.469 . . . . 55.44 110.856 -179.909 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.466 ' HA3' ' HA ' ' A' ' 19' ' ' CYS . . . -154.81 -123.91 0.88 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.699 -0.762 . . . . 63.34 112.484 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.0 m -150.8 29.25 0.68 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.83 0.348 . . . . 75.3 111.11 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -129.54 -65.47 0.11 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.721 -0.752 . . . . 60.23 112.461 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 21.0 p . . . . . 0 C--N 1.328 -0.355 0 CA-C-O 120.796 0.331 . . . . 52.33 110.891 -179.872 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 29.5 p . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.896 0.379 . . . . 24.14 110.883 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.518 ' HB3' ' HB3' ' A' ' 6' ' ' ALA . 0.0 OUTLIER -65.58 143.75 57.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.205 -0.452 . . . . 54.32 110.903 179.924 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -94.47 21.75 6.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.201 -0.454 . . . . 65.41 110.908 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 92.65 151.66 28.0 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.75 -0.738 . . . . 74.22 112.489 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 50.89 27.73 14.46 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.701 -0.762 . . . . 63.51 112.538 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.518 ' HB3' ' HB3' ' A' ' 2' ' ' LYS . . . -108.44 149.36 28.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.803 0.335 . . . . 63.52 111.135 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -75.32 135.34 40.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 72.21 110.914 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -131.2 -69.14 0.64 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.245 -0.434 . . . . 71.21 110.903 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 73.42 -85.79 0.61 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.712 -0.756 . . . . 61.05 112.52 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 32.1 p90 -51.32 -34.82 35.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.802 0.334 . . . . 71.34 110.851 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -111.73 82.4 3.89 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.541 0.686 . . . . 62.31 110.83 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.87 -7.44 21.08 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.686 2.257 . . . . 65.2 112.358 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 37.2 m-70 -130.82 21.4 5.0 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.456 . . . . 71.53 110.867 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -101.31 85.94 0.59 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.75 -0.738 . . . . 74.55 112.513 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 61.6 m -143.48 145.76 32.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.843 0.354 . . . . 63.44 110.964 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -56.84 -55.58 32.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 73.3 110.843 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.32 -159.74 35.72 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.761 -0.733 . . . . 52.12 112.458 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -88.46 50.97 2.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.865 0.364 . . . . 74.43 110.938 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.421 ' HA ' ' HA3' ' A' ' 28' ' ' GLY . 14.3 m -113.76 151.3 32.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.233 -0.44 . . . . 71.22 110.815 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -129.91 162.44 22.97 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.725 -0.75 . . . . 73.23 112.484 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 14.6 m -89.18 61.41 5.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.871 0.367 . . . . 65.35 110.868 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.533 HD22 ' HD2' ' A' ' 27' ' ' TYR . 2.5 pt? -49.77 -29.99 8.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 65.11 110.856 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.446 HG22 ' O ' ' A' ' 23' ' ' VAL . 7.0 p -142.83 20.45 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 64.24 111.111 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 108.34 -13.34 36.55 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.668 -0.777 . . . . 34.44 112.562 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -115.95 135.66 53.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.827 0.346 . . . . 75.33 110.911 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 17.5 m -64.35 109.6 1.97 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.189 -0.46 . . . . 65.24 110.874 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.533 ' HD2' HD22 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -128.76 117.59 21.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.191 -0.459 . . . . 71.32 110.979 -179.922 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.421 ' HA3' ' HA ' ' A' ' 19' ' ' CYS . . . -153.33 -132.84 1.78 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.711 -0.757 . . . . 45.32 112.504 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.9 m -150.33 29.72 0.7 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.787 0.327 . . . . 62.44 111.153 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -141.09 -55.28 0.04 OUTLIER Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.653 -0.784 . . . . 70.51 112.441 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 27.6 p . . . . . 0 C--N 1.328 -0.337 0 CA-C-O 120.765 0.316 . . . . 51.32 110.862 -179.834 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 29.0 p . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.947 0.403 . . . . 52.23 110.898 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.607 ' HB3' ' HB3' ' A' ' 6' ' ' ALA . 0.0 OUTLIER -68.55 125.89 27.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.15 -0.477 . . . . 73.13 110.828 179.978 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.73 -12.42 61.01 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 75.12 110.931 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 131.69 152.13 7.09 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.712 -0.756 . . . . 72.11 112.455 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 51.6 26.18 15.65 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.741 -0.743 . . . . 75.2 112.473 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.607 ' HB3' ' HB3' ' A' ' 2' ' ' LYS . . . -103.44 151.54 22.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.753 0.311 . . . . 71.22 111.104 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -77.85 136.22 38.04 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.257 -0.429 . . . . 74.22 110.868 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -131.19 -70.45 0.6 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.221 -0.445 . . . . 53.43 110.878 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 75.08 -85.17 0.8 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.65 -0.786 . . . . 61.44 112.505 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -51.88 -35.97 46.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.855 0.36 . . . . 74.31 110.856 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -110.58 82.14 2.73 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.621 0.724 . . . . 64.51 110.897 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -8.56 23.93 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.729 2.286 . . . . 74.41 112.377 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 6.1 m170 -128.24 19.3 6.41 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.246 -0.434 . . . . 71.22 110.87 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -100.47 88.36 0.76 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.818 -0.706 . . . . 65.51 112.519 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 65.6 m -144.76 143.83 30.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.866 0.365 . . . . 70.03 110.867 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -54.61 -56.76 15.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 63.12 110.927 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.32 -158.6 34.44 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.731 -0.747 . . . . 62.11 112.567 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -88.69 50.77 2.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.85 0.357 . . . . 73.14 110.878 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.411 ' HA ' ' HA3' ' A' ' 28' ' ' GLY . 14.2 m -113.5 153.75 28.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.166 -0.47 . . . . 62.13 110.831 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -132.25 162.51 23.98 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.7 -0.762 . . . . 71.51 112.471 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 14.2 m -88.97 61.3 5.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.888 0.375 . . . . 74.41 110.896 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.519 HD22 ' HD2' ' A' ' 27' ' ' TYR . 2.6 pt? -49.67 -30.14 8.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.231 -0.441 . . . . 53.21 110.919 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.435 HG22 ' O ' ' A' ' 23' ' ' VAL . 6.9 p -143.92 22.8 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.114 -0.494 . . . . 72.02 111.109 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 107.11 -15.05 40.08 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.732 -0.747 . . . . 51.1 112.481 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -114.98 135.75 53.88 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.885 0.374 . . . . 73.32 110.851 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 15.7 m -65.14 111.0 2.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 71.14 110.902 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.519 ' HD2' HD22 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -129.28 117.88 21.39 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.115 -0.493 . . . . 74.14 110.896 -179.881 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.411 ' HA3' ' HA ' ' A' ' 19' ' ' CYS . . . -153.45 -132.6 1.74 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.771 -0.728 . . . . 73.01 112.516 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.9 m -150.38 29.55 0.7 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.862 0.363 . . . . 73.42 111.116 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -141.01 -55.03 0.04 OUTLIER Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.791 -0.719 . . . . 44.2 112.547 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 26.9 p . . . . . 0 C--N 1.328 -0.358 0 CA-C-O 120.775 0.322 . . . . 71.14 110.885 -179.916 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 5.1 p . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.914 0.388 . . . . 75.31 110.905 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.8 -169.03 0.11 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 74.41 110.901 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -128.6 20.83 6.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.45 . . . . 72.02 110.851 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 88.82 152.5 25.56 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.755 -0.736 . . . . 60.03 112.552 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 51.78 25.49 15.51 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.738 -0.744 . . . . 61.0 112.464 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -107.85 157.23 18.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.778 0.323 . . . . 63.22 111.119 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -76.71 133.63 39.45 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.197 -0.456 . . . . 71.33 110.849 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -130.19 -74.14 0.55 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.24 -0.436 . . . . 64.11 110.875 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 81.5 -78.27 1.95 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.748 -0.739 . . . . 54.52 112.427 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -56.65 -34.75 67.63 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.874 0.368 . . . . 72.32 110.917 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -112.4 77.22 2.19 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.591 0.71 . . . . 71.22 110.865 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.81 -6.4 18.54 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.668 2.246 . . . . 63.32 112.327 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 9.7 p80 -138.06 24.17 2.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.445 . . . . 61.43 110.835 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -121.96 114.44 2.52 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.772 -0.728 . . . . 61.11 112.493 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -160.92 178.47 9.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.853 0.359 . . . . 70.0 110.872 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -72.4 -22.99 61.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.191 -0.459 . . . . 50.03 110.808 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -130.52 -162.17 10.61 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.748 -0.739 . . . . 71.24 112.436 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.8 m-80 -88.67 48.51 1.64 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.892 0.377 . . . . 64.33 110.92 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.412 ' HA ' ' HA3' ' A' ' 28' ' ' GLY . 7.9 m -113.09 127.43 56.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.169 -0.469 . . . . 65.21 110.879 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -104.57 157.17 16.93 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.8 -0.714 . . . . 70.2 112.499 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 13.2 m -87.3 65.17 8.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.825 0.345 . . . . 63.01 110.843 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.466 HD22 ' HD2' ' A' ' 27' ' ' TYR . 2.6 pt? -50.2 -30.41 11.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.117 -0.492 . . . . 64.42 110.848 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.444 HG22 ' O ' ' A' ' 23' ' ' VAL . 7.5 p -145.0 24.88 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.248 -0.433 . . . . 51.12 111.142 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 109.17 -23.84 22.21 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.727 -0.749 . . . . 53.2 112.479 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -106.15 130.5 54.03 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.918 0.389 . . . . 73.01 110.835 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 1.2 m -65.37 106.93 1.49 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 52.42 110.904 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.466 ' HD2' HD22 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -121.93 118.93 30.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.156 -0.474 . . . . 73.43 110.954 -179.908 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.412 ' HA3' ' HA ' ' A' ' 19' ' ' CYS . . . -153.5 -133.21 1.81 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.667 -0.778 . . . . 70.32 112.47 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.2 m -150.28 31.24 0.68 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.864 0.364 . . . . 74.53 111.126 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.418 ' O ' ' OXT' ' A' ' 31' ' ' CYS . . . -139.62 -58.47 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.711 -0.757 . . . . 75.51 112.464 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.418 ' OXT' ' O ' ' A' ' 30' ' ' GLY . 31.3 p . . . . . 0 C--N 1.328 -0.348 0 CA-C-O 120.79 0.329 . . . . 54.41 110.86 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 5.7 p . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.956 0.408 . . . . 63.33 110.887 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.62 ' HB3' ' HB3' ' A' ' 6' ' ' ALA . 0.0 OUTLIER -72.07 128.45 35.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.142 -0.481 . . . . 60.01 110.896 179.961 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -94.41 25.82 3.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 74.43 110.869 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 100.15 149.45 23.77 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.723 -0.751 . . . . 14.21 112.476 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 49.76 34.59 21.95 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.796 -0.716 . . . . 61.25 112.433 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.62 ' HB3' ' HB3' ' A' ' 2' ' ' LYS . . . -108.97 143.55 38.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.83 0.347 . . . . 70.13 111.073 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -72.59 132.32 43.61 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.181 -0.463 . . . . 75.22 110.999 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -131.35 -69.95 0.61 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.441 . . . . 60.11 110.825 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 75.14 -85.11 0.81 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.776 -0.726 . . . . 63.21 112.443 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -52.52 -36.86 56.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.901 0.382 . . . . 65.43 110.922 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -109.98 85.64 4.32 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.614 0.721 . . . . 73.14 110.88 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.83 -5.86 17.26 Favored 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.639 2.226 . . . . 64.31 112.279 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 26.0 m-70 -136.75 23.17 3.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.302 -0.408 . . . . 75.11 110.85 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -102.67 86.33 0.55 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.778 -0.725 . . . . 74.33 112.531 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 38.2 m -141.38 162.67 34.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.848 0.356 . . . . 53.23 110.934 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -60.15 -45.72 92.08 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.168 -0.469 . . . . 75.2 110.873 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -111.11 -146.24 10.52 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.748 -0.739 . . . . 72.04 112.487 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -88.9 41.08 1.01 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.907 0.384 . . . . 65.41 110.905 -179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.411 ' HA ' ' HA3' ' A' ' 28' ' ' GLY . 67.8 m -89.48 142.22 27.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 75.14 110.855 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -126.01 148.85 17.19 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.74 -0.743 . . . . 63.4 112.498 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 14.1 m -88.73 63.74 7.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.846 0.355 . . . . 70.45 110.862 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -49.64 -27.98 5.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.187 -0.461 . . . . 74.12 110.912 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.433 HG22 ' O ' ' A' ' 23' ' ' VAL . 7.1 p -145.31 18.88 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.177 -0.465 . . . . 72.04 111.162 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 109.65 -10.26 32.62 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.733 -0.746 . . . . 74.51 112.508 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -115.09 129.45 56.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.906 0.384 . . . . 74.32 110.879 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 5.8 m -59.18 127.91 34.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.151 -0.477 . . . . 74.51 110.838 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -150.05 116.87 5.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 75.02 110.989 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.411 ' HA3' ' HA ' ' A' ' 19' ' ' CYS . . . -154.28 -133.98 1.87 Allowed Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.754 -0.736 . . . . 53.24 112.482 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.406 HG22 ' O ' ' A' ' 29' ' ' THR . 3.8 m -150.9 32.79 0.6 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.857 0.36 . . . . 65.31 111.124 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -150.4 15.79 0.98 Allowed Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.768 -0.729 . . . . 62.2 112.502 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 5.6 m . . . . . 0 C--N 1.329 -0.311 0 CA-C-O 120.801 0.334 . . . . 73.32 110.907 -179.965 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 2.5 p . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.904 0.383 . . . . 62.24 110.906 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -72.05 -168.66 0.41 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 71.32 110.886 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -126.78 17.03 7.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 44.03 110.852 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 87.56 157.08 30.94 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.806 -0.711 . . . . 73.34 112.488 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 51.83 27.33 20.26 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.718 -0.753 . . . . 74.43 112.525 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -115.96 155.37 28.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.735 0.302 . . . . 74.41 111.14 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -74.18 131.38 41.2 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.215 -0.448 . . . . 72.43 110.891 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -129.5 -76.23 0.55 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.234 -0.439 . . . . 43.03 110.902 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 84.15 -60.58 4.82 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.713 -0.756 . . . . 64.33 112.515 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 56.1 p90 -63.21 -38.95 93.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.882 0.373 . . . . 71.35 110.872 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -116.03 76.14 6.2 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.582 0.706 . . . . 72.13 110.865 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.75 -5.4 16.12 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.65 2.233 . . . . 72.31 112.323 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -144.33 24.14 1.61 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 60.15 110.838 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -105.18 -91.3 2.22 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.697 -0.763 . . . . 30.55 112.474 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 49.93 -170.45 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.92 0.39 . . . . 54.53 110.853 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -81.52 -59.16 2.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.475 . . . . 70.52 110.897 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.73 -156.55 32.13 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.773 -0.727 . . . . 73.33 112.522 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 11.2 p-10 -88.96 47.8 1.55 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.834 0.349 . . . . 74.52 110.878 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.413 ' HA ' ' HA3' ' A' ' 28' ' ' GLY . 9.5 m -112.64 138.74 48.99 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.182 -0.463 . . . . 71.45 110.87 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -118.8 156.35 15.7 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.728 -0.749 . . . . 71.11 112.518 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 5.7 m -87.98 65.98 8.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.892 0.377 . . . . 53.12 110.913 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -49.67 -31.41 10.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.124 -0.489 . . . . 71.43 110.909 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.471 HG22 ' O ' ' A' ' 23' ' ' VAL . 9.8 p -144.89 28.85 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 64.22 111.076 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 110.2 -38.59 3.24 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.83 -0.7 . . . . 54.25 112.445 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -96.1 131.27 42.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.862 0.363 . . . . 75.0 110.886 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 1.7 m -64.46 126.15 26.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.248 -0.433 . . . . 74.32 110.87 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.426 ' O ' ' CG ' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -137.42 118.53 14.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.19 -0.459 . . . . 71.55 110.943 -179.931 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.413 ' HA3' ' HA ' ' A' ' 19' ' ' CYS . . . -153.98 -134.33 1.94 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.758 -0.734 . . . . 63.32 112.51 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.1 m -150.14 30.67 0.7 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.782 0.325 . . . . 64.12 111.179 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -140.38 -55.4 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.782 -0.723 . . . . 64.31 112.526 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 27.1 p . . . . . 0 C--N 1.328 -0.337 0 CA-C-O 120.817 0.342 . . . . 64.25 110.829 -179.866 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 5.2 p . . . . . 0 C--O 1.232 0.18 0 CA-C-O 120.921 0.391 . . . . 72.55 110.835 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.691 ' HB3' ' HB3' ' A' ' 6' ' ' ALA . 0.0 OUTLIER -73.77 142.24 46.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 73.23 110.82 179.922 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -98.73 20.43 13.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.173 -0.467 . . . . 72.25 110.876 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 101.82 150.03 22.99 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.783 -0.722 . . . . 73.12 112.47 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 49.93 29.45 14.0 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.745 -0.741 . . . . 75.35 112.459 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.691 ' HB3' ' HB3' ' A' ' 2' ' ' LYS . . . -107.99 129.69 55.1 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.747 0.308 . . . . 74.13 111.116 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -59.58 132.62 54.55 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.261 -0.427 . . . . 74.33 110.925 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -128.48 -73.04 0.59 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 75.42 110.869 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 78.33 -83.16 1.22 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.744 -0.741 . . . . 74.21 112.454 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -53.68 -34.56 59.12 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.845 0.355 . . . . 71.44 110.897 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -113.16 85.67 8.54 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.654 0.74 . . . . 64.05 110.85 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.82 -8.08 22.7 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.731 2.287 . . . . 65.12 112.33 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 25.6 p80 -133.02 21.51 4.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 72.21 110.875 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -99.35 86.33 0.7 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.743 -0.741 . . . . 74.45 112.555 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 52.6 m -141.9 154.8 45.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.841 0.353 . . . . 73.43 110.932 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -72.99 -22.39 60.69 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.171 -0.468 . . . . 74.54 110.875 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -121.27 -159.51 10.74 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.806 -0.711 . . . . 64.23 112.496 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -89.3 48.58 1.63 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.873 0.368 . . . . 74.15 110.861 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.466 ' HA ' ' HA3' ' A' ' 28' ' ' GLY . 6.5 m -110.54 149.83 29.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 62.25 110.858 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -127.71 156.9 20.79 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.693 -0.765 . . . . 52.25 112.49 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 22.4 m -88.88 57.94 4.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.875 0.369 . . . . 74.33 110.893 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.548 ' HG ' HG22 ' A' ' 23' ' ' VAL . 2.5 pt? -48.09 -33.97 8.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.194 -0.457 . . . . 74.43 110.922 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.622 HG23 ' CD2' ' A' ' 25' ' ' PHE . 1.8 m -133.3 9.63 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.471 . . . . 75.34 111.053 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 116.01 -7.52 19.19 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.679 -0.772 . . . . 53.12 112.449 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.622 ' CD2' HG23 ' A' ' 23' ' ' VAL . 1.3 m-85 -119.6 136.08 54.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.919 0.39 . . . . 74.33 110.877 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 11.9 m -63.26 102.37 0.39 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.137 -0.483 . . . . 73.43 110.905 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.546 ' HD2' HD22 ' A' ' 22' ' ' LEU . 0.0 OUTLIER -118.75 115.07 23.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.202 -0.454 . . . . 74.3 110.892 -179.801 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.466 ' HA3' ' HA ' ' A' ' 19' ' ' CYS . . . -154.22 -140.02 2.95 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.767 -0.73 . . . . 61.24 112.522 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 4.0 m -150.82 36.89 0.63 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.796 0.331 . . . . 54.32 111.099 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -146.66 -38.06 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.696 -0.764 . . . . 62.02 112.436 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 33.3 m . . . . . 0 C--N 1.328 -0.335 0 CA-C-O 120.786 0.327 . . . . 74.53 110.856 -179.863 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 2.6 p . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.937 0.399 . . . . 44.43 110.845 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.48 -167.96 0.05 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.158 -0.474 . . . . 74.13 110.896 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -129.01 18.84 6.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.231 -0.441 . . . . 54.05 110.869 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 86.1 157.0 28.77 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.726 -0.75 . . . . 73.4 112.52 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 51.96 26.73 19.64 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.81 -0.709 . . . . 73.1 112.503 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -114.79 155.87 25.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.8 0.334 . . . . 75.22 111.111 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -74.48 131.08 40.72 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.155 -0.475 . . . . 64.02 110.905 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -128.23 -75.95 0.56 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.258 -0.428 . . . . 71.41 110.967 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 85.08 -64.71 4.18 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.705 -0.76 . . . . 33.23 112.492 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 55.7 p90 -61.65 -39.27 90.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.932 0.396 . . . . 75.34 110.873 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -114.43 76.52 3.85 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.595 0.712 . . . . 42.42 110.839 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.74 -5.37 16.04 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.7 2.267 . . . . 73.03 112.372 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 11.3 p80 -144.9 23.26 1.56 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 74.15 110.9 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -101.65 -92.34 2.17 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.72 -0.752 . . . . 44.41 112.451 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 50.29 -171.2 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.878 0.371 . . . . 65.52 110.881 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -78.27 -62.26 1.74 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 63.34 110.858 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.66 -153.16 27.66 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.744 -0.741 . . . . 55.3 112.51 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -89.03 46.36 1.38 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.933 0.396 . . . . 75.32 110.875 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.419 ' HA ' ' HA3' ' A' ' 28' ' ' GLY . 34.0 m -107.38 134.95 49.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.125 -0.489 . . . . 72.34 110.835 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -117.57 154.26 16.77 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.699 -0.762 . . . . 71.21 112.482 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 5.4 m -88.13 67.4 8.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.89 0.376 . . . . 71.12 110.939 -179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -50.54 -27.99 7.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.469 . . . . 60.4 110.918 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.466 HG22 ' O ' ' A' ' 23' ' ' VAL . 9.5 p -148.01 28.28 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 73.55 111.151 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 109.9 -36.34 4.35 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.767 -0.73 . . . . 62.02 112.46 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 22.2 m-85 -97.52 129.18 44.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.951 0.405 . . . . 61.34 110.825 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 2.7 m -62.65 130.32 44.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.167 -0.47 . . . . 70.34 110.867 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.44 ' O ' ' CG ' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -142.84 117.88 10.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.129 -0.487 . . . . 70.4 110.975 -179.882 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.419 ' HA3' ' HA ' ' A' ' 19' ' ' CYS . . . -153.9 -132.26 1.66 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.729 -0.748 . . . . 33.03 112.503 179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.0 m -150.36 29.27 0.71 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.84 0.352 . . . . 75.04 111.153 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.548 ' O ' ' OXT' ' A' ' 31' ' ' CYS . . . -138.11 -56.93 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.743 -0.741 . . . . 61.01 112.497 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.548 ' OXT' ' O ' ' A' ' 30' ' ' GLY . 29.9 p . . . . . 0 C--N 1.329 -0.291 0 CA-C-O 120.785 0.326 . . . . 62.14 110.846 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 2.6 p . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.829 0.347 . . . . 72.41 110.892 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.18 -168.8 0.68 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.192 -0.458 . . . . 73.01 110.878 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.466 ' O ' ' OXT' ' A' ' 31' ' ' CYS . 0.5 OUTLIER -130.64 18.73 5.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.45 . . . . 71.0 110.855 -179.887 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 95.44 155.92 31.49 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.667 -0.777 . . . . 42.53 112.478 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 51.64 27.49 19.18 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.825 -0.703 . . . . 51.33 112.423 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -113.29 149.61 33.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.792 0.33 . . . . 52.21 111.097 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -70.59 131.38 43.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.174 -0.466 . . . . 74.22 110.949 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -129.19 -76.11 0.55 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.228 -0.442 . . . . 75.21 110.85 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 85.98 -69.77 3.13 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.761 -0.733 . . . . 51.4 112.432 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 54.8 p90 -59.63 -39.43 84.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.795 0.331 . . . . 71.31 110.867 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -112.73 76.89 2.27 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.61 0.719 . . . . 74.32 110.83 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.68 -5.55 16.42 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.668 2.246 . . . . 70.32 112.36 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 11.6 p80 -144.45 23.57 1.62 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.259 -0.428 . . . . 61.42 110.808 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -99.65 -92.86 2.07 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.721 -0.752 . . . . 74.44 112.496 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 49.99 -170.16 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.936 0.398 . . . . 71.44 110.824 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -83.93 -59.87 2.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 52.25 110.912 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.79 -155.36 30.74 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.779 -0.724 . . . . 65.35 112.447 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -89.4 43.41 1.14 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.9 0.381 . . . . 61.35 110.947 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 5.4 m -107.13 121.76 45.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 55.21 110.879 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -103.55 155.81 17.84 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.742 -0.742 . . . . 62.43 112.458 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 5.0 m -88.32 71.13 9.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.857 0.36 . . . . 74.31 110.886 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.411 HD23 ' CD2' ' A' ' 27' ' ' TYR . 1.5 pp -47.49 -32.94 5.71 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.212 -0.449 . . . . 62.43 110.919 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.469 HG22 ' O ' ' A' ' 23' ' ' VAL . 9.9 p -147.29 30.83 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.2 -0.455 . . . . 71.23 111.163 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 109.66 -31.07 7.85 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.691 -0.766 . . . . 73.01 112.516 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 26.4 m-85 -101.05 124.23 46.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.965 0.412 . . . . 73.31 110.852 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 6.8 m -61.33 131.41 50.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.112 -0.495 . . . . 73.4 110.875 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.465 ' O ' ' CG ' ' A' ' 27' ' ' TYR . 0.0 OUTLIER -142.44 117.03 9.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.161 -0.472 . . . . 73.15 110.864 -179.894 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -154.09 -133.21 1.77 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.688 -0.768 . . . . 52.4 112.469 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.3 m -151.17 30.87 0.61 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.853 0.359 . . . . 65.21 111.158 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -150.39 15.21 0.97 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.775 -0.726 . . . . 21.11 112.481 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.466 ' OXT' ' O ' ' A' ' 3' ' ' SER . 4.8 m . . . . . 0 C--N 1.328 -0.33 0 CA-C-O 120.775 0.321 . . . . 74.43 110.905 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 17.6 p . . . . . 0 C--O 1.232 0.179 0 CA-C-O 120.886 0.374 . . . . 73.41 110.933 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.46 166.66 18.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.282 -0.417 . . . . 71.05 110.879 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -118.5 19.61 13.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 71.23 110.827 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 96.9 149.46 25.57 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.751 -0.738 . . . . 70.11 112.431 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 50.67 26.82 11.1 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.728 -0.749 . . . . 70.21 112.525 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -106.29 130.09 54.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.764 0.316 . . . . 74.4 111.1 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -58.52 134.21 56.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 61.22 110.958 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -126.88 -81.11 0.61 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.265 -0.425 . . . . 73.24 110.888 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 76.16 -62.61 2.96 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.758 -0.734 . . . . 42.21 112.481 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -50.43 -34.13 23.43 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.876 0.369 . . . . 73.13 110.903 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -146.08 115.87 4.73 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.628 0.728 . . . . 73.1 110.865 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.75 -8.01 22.51 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.665 2.243 . . . . 70.01 112.398 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -128.17 21.28 6.25 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.21 -0.45 . . . . 72.11 110.821 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -88.32 65.67 3.36 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.705 -0.759 . . . . 53.21 112.48 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 12.9 m -138.76 156.9 46.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.82 0.343 . . . . 75.13 110.94 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -53.5 -61.89 2.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 44.41 110.883 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.51 -152.26 26.06 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.755 -0.736 . . . . 74.44 112.517 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -88.79 46.23 1.37 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.854 0.359 . . . . 62.22 110.874 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.41 ' HA ' ' HA3' ' A' ' 28' ' ' GLY . 62.5 m -91.2 129.69 37.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.229 -0.441 . . . . 74.33 110.88 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -112.54 150.29 18.31 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.749 -0.738 . . . . 52.54 112.457 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 38.2 m -89.21 65.2 7.23 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.903 0.383 . . . . 54.21 110.87 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.897 ' HG ' HG23 ' A' ' 23' ' ' VAL . 2.6 pt? -44.77 -36.21 3.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.156 -0.475 . . . . 74.42 110.918 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.897 HG23 ' HG ' ' A' ' 22' ' ' LEU . 25.8 t -134.91 8.23 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.465 . . . . 70.51 111.183 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 117.62 5.19 14.42 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.811 -0.709 . . . . 51.54 112.509 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -128.39 130.5 47.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.835 0.35 . . . . 73.41 110.903 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 56.1 m -51.57 124.46 12.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.156 -0.475 . . . . 64.51 110.84 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.433 ' CD2' HD22 ' A' ' 22' ' ' LEU . 0.3 OUTLIER -150.52 111.17 4.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 74.33 110.928 -179.937 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.41 ' HA3' ' HA ' ' A' ' 19' ' ' CYS . . . -153.78 -127.12 1.15 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.747 -0.739 . . . . 62.43 112.488 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.0 m -150.36 31.08 0.67 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.829 0.347 . . . . 75.52 111.16 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -138.48 -55.07 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.676 -0.773 . . . . 73.33 112.491 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.665 ' SG ' ' OXT' ' A' ' 31' ' ' CYS . 14.0 p . . . . . 0 C--N 1.33 -0.246 0 CA-C-O 120.806 0.336 . . . . 70.21 110.86 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 1.8 p . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.934 0.397 . . . . 64.11 110.869 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.9 mmpt? -76.15 -168.2 0.89 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.137 -0.483 . . . . 72.01 110.894 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.2 m -121.67 13.19 10.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.235 -0.439 . . . . 75.33 110.875 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 92.29 154.33 30.83 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.706 -0.759 . . . . 74.13 112.495 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 49.84 46.52 40.02 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.76 -0.733 . . . . 70.42 112.448 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -135.28 148.22 49.46 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.776 0.322 . . . . 43.04 111.116 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -64.12 128.79 37.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.16 -0.473 . . . . 73.4 110.945 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.7 p -117.48 -54.24 2.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.445 . . . . 63.34 110.876 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 70.57 -81.73 0.39 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.697 -0.763 . . . . 71.55 112.525 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 51.5 p90 -60.6 -37.18 80.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.873 0.368 . . . . 73.03 110.853 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -112.53 75.47 1.8 Allowed Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 121.608 0.718 . . . . 73.01 110.885 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.8 -5.84 17.2 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.678 2.252 . . . . 72.4 112.348 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -142.18 21.75 2.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.224 -0.444 . . . . 70.13 110.891 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -87.57 -95.07 0.94 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.723 -0.751 . . . . 30.01 112.453 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 51.07 -171.77 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.886 0.374 . . . . 72.33 110.84 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -89.14 -57.98 2.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.166 -0.47 . . . . 73.13 110.927 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -89.76 -157.08 32.79 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.765 -0.731 . . . . 75.44 112.478 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -88.44 49.32 1.77 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.841 0.353 . . . . 52.4 110.863 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.466 ' HA ' ' HA3' ' A' ' 28' ' ' GLY . 86.2 m -102.33 123.5 46.24 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.156 -0.475 . . . . 71.5 110.937 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -100.01 149.55 18.79 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.691 -0.766 . . . . 72.54 112.57 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 69.3 m -89.11 68.63 8.26 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.807 0.337 . . . . 73.2 110.862 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.61 ' HG ' HG22 ' A' ' 23' ' ' VAL . 2.5 pt? -49.29 -31.73 9.59 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.258 -0.428 . . . . 71.21 110.854 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.61 HG22 ' HG ' ' A' ' 22' ' ' LEU . 3.3 m -142.18 23.48 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.126 -0.488 . . . . 70.13 111.149 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 109.94 -29.45 9.3 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.753 -0.737 . . . . 75.23 112.506 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.49 ' CD2' HG23 ' A' ' 23' ' ' VAL . 0.6 OUTLIER -98.77 130.88 45.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.959 0.409 . . . . 72.23 110.854 -179.868 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 87.1 m -57.68 126.91 29.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 64.3 110.871 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.486 ' HD2' HD22 ' A' ' 22' ' ' LEU . 0.1 OUTLIER -151.26 111.19 4.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.169 -0.469 . . . . 55.44 110.856 -179.909 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.466 ' HA3' ' HA ' ' A' ' 19' ' ' CYS . . . -154.81 -123.91 0.88 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.699 -0.762 . . . . 63.34 112.484 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 3.0 m -150.8 29.25 0.68 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.83 0.348 . . . . 75.3 111.11 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -129.54 -65.47 0.11 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.721 -0.752 . . . . 60.23 112.461 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 21.0 p . . . . . 0 C--N 1.328 -0.355 0 CA-C-O 120.796 0.331 . . . . 52.33 110.891 -179.872 . . . . . . . . 0 0 . 1 stop_ save_